cDNA accession Links to the sequence |
Tissue most 5' clones in red |
Match mRNA |
From bp to bp in mRNA |
From bp to bp in accs. |
Clone encodes complete protein (with AA variation) |
Features | Anomalies detected by AceView |
Accession match over (% length) |
Base differences relative to genome (% identity) |
AA091979 | .e | 149 to 358 | 1 to 203 | 203/203 (100 %) | 20 diff (90.2 %id) | ||||
AA094282 | .e | 209 to 462 | 1 to 252 | 252/280 (90 %) | 3 diff (99.0 %id) | ||||
AA300665 | testis | .e | 159 to 452 | 1 to 294 | 294/294 (100 %) | 0 diff (100 %id) | |||
AA306527 | .e | 279 to 617 | 1 to 339 | 339/339 (100 %) | 0 diff (100 %id) | ||||
AA311499 | .h | 1 to 470 | 5 to 474 | V116X | tiling clone, | 474/474 (100 %) | 0 diff (100 %id) | ||
AA311842 | .e | 158 to 416 | 1 to 259 | 259/259 (100 %) | 0 diff (100 %id) | ||||
AA336624 | endometrium | .e | 349 to 670 | 1 to 322 | 322/322 (100 %) | 0 diff (100 %id) | |||
AA340971 | Kidney | .e | 371 to 668 | 1 to 298 | 298/298 (100 %) | 0 diff (100 %id) | |||
AA353926 | .e | 163 to 333 | 1 to 171 | 171/171 (100 %) | 0 diff (100 %id) | ||||
AA357996 | lung | .e | 184 to 413 | 1 to 230 | 230/230 (100 %) | 0 diff (100 %id) | |||
AA363578 | Bone | .e | 233 to 416 | 1 to 184 | 184/184 (100 %) | 1 diff (99.5 %id) | |||
AA372302 | colon | .e | 182 to 459 | 1 to 278 | 278/278 (100 %) | 2 diff (99.3 %id) | |||
AB055774 | .e | 128 to 177 | 1 to 50 | 50/50 (100 %) | 0 diff (100 %id) | ||||
AB209386 | brain | .i | 1 to 5429 | 1 to 5429 | exact | tiling clone, | 5429/5429 (100 %) | 2 diff (100.0 %id) | |
AI540881 | Tissue culture | .j | 1 to 407 | 17 to 424 | D2X L3P K4Q A5X Q6X ... | tiling clone, | 408/856 (47 %) | 7 diff (99.2 %id) | |
AJ712580 | bone marrow | .d | 41 to 439 | 1 to 399 | 399/399 (100 %) | 0 diff (100 %id) | |||
AJ713172 | bone marrow | .d | 41 to 462 | 1 to 422 | 422/422 (100 %) | 0 diff (100 %id) | |||
AJ714662. matches multiple genes | bone marrow | .e | 263 to 329 | 1 to 67 | also hits gene RPS7P1 | 67/67 (100 %) | 0 diff (100 %id) | ||
AK092027 | .k | 418 to 3001 | 1 to 2584 | tiling clone, available from FLJ, | 2584/2584 (100 %) | 2 diff (100.0 %id) | |||
AK311794 | Spleen | .e | 128 to 756 | 1 to 629 | exact | 629/629 (100 %) | 0 diff (100 %id) | ||
DA033086 | .m | 3 to 559 | 2 to 558 | capped | 557/557 (100 %) | 0 diff (100 %id) | |||
AW371356 | breast | .e | 174 to 395 | 222 to 1 | 222/222 (100 %) | 3 diff (98.7 %id) | |||
AW376959 | colon | .i | 1967 to 2600 | 637 to 4 | 634/637 (99 %) | 0 diff (100 %id) | |||
AW381348 | head_neck | .e | 177 to 312 | 1 to 136 | 136/136 (100 %) | 4 diff (97.1 %id) | |||
AW852892 | colon | .i | 776 to 1367 | 617 to 26 | 592/617 (95 %) | 0 diff (100 %id) | |||
AW884917 | ovary | .i | 4574 to 4989 | 214 to 625 | 412/646 (63 %) | 9 diff (98.7 %id) | |||
AW885180 | ovary | .i | 4783 to 5020 | 254 to 21 | 234/269 (86 %) | 0 diff (100 %id) | |||
AW974233 | .n | 560 to 1034 | 1 to 475 | exact | tiling clone, | 475/475 (100 %) | 15 diff (96.9 %id) | ||
BC071919 | Brain, neuroblastoma | .e | 146 to 792 | 1 to 647 | exact | available from MGC, AAA | Possibly primed on the genome, locally A rich (13/15 A in genome downstream of last aligned base) | 647/647 (100 %) | 0 diff (100 %id) |
BE079292 | breast | .f | 1305 to 1833 | 1 to 531 | tiling clone, | 531/531 (100 %) | 9 diff (98.4 %id) | ||
BE088686 | breast | .i | 539 to 972 | 433 to 4 | Submitted on the opposite strand | 430/433 (99 %) | 0 diff (100 %id) | ||
BE090895 | breast | .e | 317 to 603 | 293 to 4 | Submitted on the opposite strand | 290/295 (98 %) | 3 diff (99.0 %id) | ||
BF172717 | blood | .e | 149 to 322 | 1 to 182 | 182/213 (85 %) | 17 diff (92.1 %id) | |||
BF760584 | colon | .e | 463 to 632 | 196 to 28 | Submitted on the opposite strand | 169/196 (86 %) | 0 diff (100 %id) | ||
BI048266 | stomach | .e | 549 to 650 | 106 to 5 | 102/106 (96 %) | 0 diff (100 %id) | |||
BI057314 | placenta_normal | .i | 1432 to 1583 | 31 to 182 | 152/182 (83 %) | 6 diff (96.8 %id) | |||
BM090703 | Fetal Pancreas (4 Pooled Donors, 18 - 20weeks, Stratagene #738023) | .e | 260 to 403 | 1 to 144 | 144/146 (98 %) | 17 diff (88.4 %id) | |||
BM353815 | Pancreas, Purified pancreatic islet | .e | 260 to 574 | 1 to 314 | 314/314 (100 %) | 3 diff (99.1 %id) | |||
AV758627 | bone marrow | .d | 4 to 663 | 71 to 731 | K169X V176A G182X K183Q D184G ... | tiling clone, | 661/705 (93 %) | 11 diff (98.5 %id) | |
BQ302687 | breast | .f | 1248 to 1830 | 45 to 632 | tiling clone, | 588/632 (93 %) | 6 diff (99.1 %id) | ||
BF727313 | eye, lens | .e | 149 to 792 | 1 to 644 | exact | AAA | Possibly primed on the genome, locally A rich (13/15 A in genome downstream of last aligned base) | 644/644 (100 %) | 0 diff (100 %id) |
X85625 | .e | 548 to 677 | 133 to 3 | 131/137 (95 %) | 0 diff (100 %id) | ||||
X85546 | .e | 167 to 425 | 256 to 1 | 256/273 (93 %) | 3 diff (99.0 %id) | ||||
CD177612 | embryonic trophoblasts, made from WA01 stemcells | .e | 119 to 792 | 14 to 687 | exact | AAA | Possibly primed on the genome, locally A rich (13/15 A in genome downstream of last aligned base) | 674/687 (98 %) | 5 diff (99.3 %id) |
CD249668 | embryonic stem cells, WA01, passage 38 | .c | 1 to 703 | 20 to 722 | K111E | tiling clone, AAA | Possibly primed on the genome, locally A rich (13/15 A in genome downstream of last aligned base) | 709/722 (98 %) | 7 diff (99.1 %id) |
CD250222 | embryonic stem cells, WA01, passage 38 | .d | 18 to 493 | 21 to 503 | 483/931 (51 %) | 14 diff (98.5 %id) | |||
CD610324 | .e | 160 to 322 | 190 to 28 | 163/190 (85 %) | 1 diff (99.5 %id) | ||||
BU656094 | blood | .f | 175 to 694 | 1 to 520 | 520/520 (100 %) | 1 diff (99.9 %id) | |||
BU664385 | blood | .e | 1 to 704 | 2 to 705 | tiling clone, | 704/706 (99 %) | 8 diff (98.9 %id) | ||
CN291518 | embryonic stem cells, DMSO-treated H9 cellline | .i | 2903 to 3189 | 1 to 287 | 287/287 (100 %) | 0 diff (100 %id) | |||
CN295720 | embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 | .b | 45 to 420 | 1 to 377 | 377/377 (100 %) | 1 diff (99.8 %id) | |||
CN301220 | embryonic stem cells, DMSO-treated H9 cellline | .e | 583 to 787 | 220 to 16 | AAA | Submitted on the opposite strand | 205/217 (94 %) | 2 diff (99.1 %id) | |
CN301221 | embryonic stem cells, DMSO-treated H9 cellline | .e | 195 to 404 | 1 to 210 | 210/210 (100 %) | 1 diff (99.6 %id) | |||
CN301232 | embryonic stem cells, DMSO-treated H9 cellline | .e | 145 to 792 | 1 to 648 | exact | AAA | Possibly primed on the genome, locally A rich (13/15 A in genome downstream of last aligned base) | 648/648 (100 %) | 0 diff (100 %id) |
CN301233 | embryonic stem cells, DMSO-treated H9 cellline | .e | 77 to 789 | 1 to 713 | exact | AAA | Possibly primed on the genome, locally A rich (13/15 A in genome downstream of last aligned base) | 713/713 (100 %) | 0 diff (100 %id) |
CN301240 | embryonic stem cells, DMSO-treated H9 cellline | .e | 142 to 789 | 1 to 648 | exact | AAA | Possibly primed on the genome, locally A rich (13/15 A in genome downstream of last aligned base) | 648/648 (100 %) | 0 diff (100 %id) |
CN301246 | embryonic stem cells, DMSO-treated H9 cellline | .e | 140 to 792 | 1 to 653 | exact | AAA | Possibly primed on the genome, locally A rich (13/15 A in genome downstream of last aligned base) | 653/653 (100 %) | 0 diff (100 %id) |
CN301252 | embryonic stem cells, DMSO-treated H9 cellline | .e | 71 to 740 | 1 to 670 | 670/670 (100 %) | 1 diff (99.9 %id) | |||
CN301260 | embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 | .e | 138 to 792 | 2 to 656 | exact | AAA | Possibly primed on the genome, locally A rich (13/15 A in genome downstream of last aligned base) | 655/656 (99 %) | 6 diff (99.1 %id) |
CN301273 | embryonic stem cells, cell lines H1, H7, andH9 | .e | 129 to 750 | 9 to 630 | 622/630 (98 %) | 6 diff (99.1 %id) | |||
CN301275 | embryonic stem cells, DMSO-treated H9 cellline | .e | 158 to 782 | 1 to 625 | exact | 625/625 (100 %) | 0 diff (100 %id) | ||
CN301277 | embryonic stem cells, DMSO-treated H9 cellline | .e | 147 to 777 | 8 to 638 | exact | 631/639 (98 %) | 1 diff (99.9 %id) | ||
CN301279 | embryonic stem cells, DMSO-treated H9 cellline | .e | 147 to 792 | 1 to 646 | exact | AAA | Possibly primed on the genome, locally A rich (13/15 A in genome downstream of last aligned base) | 646/646 (100 %) | 0 diff (100 %id) |
CN301281 | embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 | .e | 145 to 782 | 1 to 638 | exact | 638/638 (100 %) | 0 diff (100 %id) | ||
CN301287 | embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 | .e | 145 to 782 | 1 to 638 | exact | 638/638 (100 %) | 0 diff (100 %id) | ||
CN301298 | embryonic stem cells, DMSO-treated H9 cellline | .e | 183 to 388 | 1 to 206 | 206/206 (100 %) | 0 diff (100 %id) | |||
CN301303 | embryonic stem cells, DMSO-treated H9 cellline | .e | 138 to 782 | 2 to 646 | exact | 645/646 (99 %) | 6 diff (99.1 %id) | ||
CN301306 | embryonic stem cells, DMSO-treated H9 cellline | .e | 183 to 405 | 1 to 223 | 223/223 (100 %) | 1 diff (99.6 %id) | |||
CN301309 | embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 | .e | 143 to 782 | 1 to 640 | exact | 640/640 (100 %) | 0 diff (100 %id) | ||
CN301310 | embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 | .e | 138 to 789 | 2 to 653 | exact | AAA | Possibly primed on the genome, locally A rich (13/15 A in genome downstream of last aligned base) | 652/653 (99 %) | 6 diff (99.1 %id) |
BY998878 | .e | 192 to 745 | 1 to 554 | Submitted on the opposite strand | 554/555 (99 %) | 1 diff (99.9 %id) | |||
CR598181 | B cells (Ramos cell line) Cot 25-normalized | .e | 104 to 792 | 1 to 689 | exact | 689/689 (100 %) | 0 diff (100 %id) | ||
CR600310 | placenta | .e | 152 to 793 | 1 to 642 | exact | 642/642 (100 %) | 0 diff (100 %id) | ||
CR604018 | Neuroblastoma Cot 25-normalized | .e | 152 to 792 | 1 to 641 | exact | 641/641 (100 %) | 0 diff (100 %id) | ||
CR611842 | B cells (Ramos cell line) Cot 25-normalized | .e | 152 to 793 | 1 to 642 | exact | 642/642 (100 %) | 0 diff (100 %id) | ||
CR620103 | Placenta Cot 25-normalized | .e | 152 to 793 | 1 to 642 | exact | 642/642 (100 %) | 0 diff (100 %id) | ||
CR624620 | Neuroblastoma Cot 50-normalized | .e | 152 to 792 | 1 to 641 | exact | 641/641 (100 %) | 0 diff (100 %id) | ||
BX392817 | Placenta Cot 25-normalized | .e | 254 to 791 | 536 to 1 | 536/536 (100 %) | 5 diff (99.1 %id) | |||
BX427526 | fetal liver, Liver | .e | 152 to 742 | 597 to 1 | 597/597 (100 %) | 12 diff (98.0 %id) | |||
CA393610 | eye, RPE/choroid | .e | 143 to 778 | 1 to 636 | exact | 636/636 (100 %) | 0 diff (100 %id) | ||
DA459874 | tongue, tumor tissue | .n | 150 to 546 | 2 to 398 | tiling clone, capped | 397/398 (99 %) | 2 diff (99.5 %id) | ||
CU446896. matches multiple genes | epidermis | .e | 224 to 664 | 449 to 8 | Submitted on the opposite strand, also hits gene RPS7P1 | 442/449 (98 %) | 0 diff (100 %id) | ||
CU450455 | epidermis | .e | 172 to 664 | 501 to 8 | Submitted on the opposite strand | 494/507 (97 %) | 2 diff (99.7 %id) | ||
CU453332 | epidermis | .e | 172 to 664 | 501 to 8 | Submitted on the opposite strand | 494/507 (97 %) | 3 diff (99.5 %id) | ||
EC440198 | Prostate | .e | 181 to 276 | 1 to 96 | 96/96 (100 %) | 0 diff (100 %id) | |||
EC447835 | Prostate | .e | 529 to 627 | 1 to 99 | 99/99 (100 %) | 2 diff (98.0 %id) | |||
EC454840 | Prostate | .e | 578 to 675 | 1 to 98 | 98/98 (100 %) | 0 diff (100 %id) | |||
EC479888 | Prostate | .e | 152 to 253 | 1 to 102 | 102/102 (100 %) | 0 diff (100 %id) | |||
EC480246 | Prostate | .e | 152 to 253 | 1 to 102 | 102/102 (100 %) | 0 diff (100 %id) | |||
EC480427 | Prostate | .e | 505 to 605 | 1 to 97 | 97/97 (100 %) | 6 diff (93.9 %id) | |||
EC497258 | Prostate | .e | 175 to 274 | 1 to 100 | 100/100 (100 %) | 0 diff (100 %id) | |||
EC510478 | Prostate | .e | 277 to 378 | 1 to 102 | 102/102 (100 %) | 2 diff (98.1 %id) | |||
EC511096 | Prostate | .e | 286 to 378 | 13 to 104 | 92/104 (88 %) | 9 diff (91.4 %id) | |||
EC538580 | Prostate | .e | 175 to 274 | 1 to 99 | 99/99 (100 %) | 4 diff (96.0 %id) | |||
EC543545. matches multiple genes | Prostate | .e | 696 to 793 | 20 to 116 | also hits gene RPS7P1 | 97/116 (83 %) | 6 diff (94.9 %id) | ||
EC543911 | Prostate | .e | 521 to 611 | 5 to 95 | 91/95 (95 %) | 7 diff (92.7 %id) | |||
EC553209 | Prostate | .e | 174 to 274 | 1 to 103 | 103/103 (100 %) | 2 diff (98.1 %id) | |||
EC560199 | Prostate | .e | 184 to 273 | 20 to 109 | 90/109 (82 %) | 8 diff (92.7 %id) | |||
EH336700. matches multiple genes | .e | 254 to 325 | 1 to 72 | also hits gene RPS7P1 | 72/72 (100 %) | 0 diff (100 %id) | |||
EL946554 | eyeball | .e | 247 to 788 | 1 to 542 | 542/542 (100 %) | 7 diff (98.8 %id) | |||
EL947246 | eyeball | .e | 151 to 388 | 52 to 294 | 243/294 (82 %) | 10 diff (96.6 %id) | |||
EL947790 | eyeball | .e | 146 to 787 | 37 to 678 | K142Q K147* | 642/678 (94 %) | 4 diff (99.5 %id) | ||
EL948355 | eyeball | .e | 337 to 700 | 1 to 362 | 362/362 (100 %) | 6 diff (98.4 %id) | |||
EL949009 | eyeball | .e | 366 to 561 | 1 to 196 | 196/196 (100 %) | 3 diff (98.5 %id) | |||
EL949025 | eyeball | .e | 185 to 768 | 1 to 582 | 582/582 (100 %) | 8 diff (98.7 %id) | |||
EL949627 | eyeball | .e | 144 to 638 | 1 to 495 | 495/495 (100 %) | 2 diff (99.6 %id) | |||
EL949656 | eyeball | .e | 144 to 692 | 1 to 549 | 549/549 (100 %) | 2 diff (99.7 %id) | |||
EL949809 | eyeball | .e | 144 to 655 | 1 to 513 | 513/513 (100 %) | 4 diff (99.3 %id) | |||
EL950313. matches multiple genes | eyeball | .e | 370 to 792 | 8 to 430 | AAA | Possibly primed on the genome, locally A rich (13/15 A in genome downstream of last aligned base), also hits gene RPS7P1 | 423/430 (98 %) | 6 diff (98.7 %id) | |
EL950373 | eyeball | .e | 269 to 792 | 1 to 524 | 524/524 (100 %) | 1 diff (99.9 %id) | |||
EL950548 | eyeball | .e | 143 to 792 | 5 to 654 | exact | AAA | Possibly primed on the genome, locally A rich (13/15 A in genome downstream of last aligned base) | 650/654 (99 %) | 0 diff (100 %id) |
EL950804 | eyeball | .e | 336 to 787 | 1 to 452 | AAA | 452/457 (98 %) | 5 diff (99.0 %id) | ||
EL951139 | eyeball | .e | 408 to 790 | 1 to 379 | AAA | 379/463 (81 %) | 7 diff (98.5 %id) | ||
EL952375 | eyeball | .e | 297 to 754 | 1 to 458 | 458/458 (100 %) | 0 diff (100 %id) | |||
EL952649 | eyeball | .i | 12 to 270 | 55 to 320 | 266/320 (83 %) | 7 diff (97.9 %id) | |||
EL952700 | eyeball | .e | 461 to 792 | 1 to 332 | AAA | Possibly primed on the genome, locally A rich (13/15 A in genome downstream of last aligned base) | 332/332 (100 %) | 3 diff (99.1 %id) | |
EL952849 | eyeball | .e | 201 to 792 | 652 to 60 | AAA | Submitted on the opposite strand | 593/593 (100 %) | 1 diff (99.9 %id) | |
EL953351 | eyeball | .e | 272 to 657 | 34 to 413 | 380/413 (92 %) | 14 diff (96.7 %id) | |||
ES308914 | occipital hair of pubic hypotrichosispatient, skin | .e | 148 to 620 | 1 to 471 | 471/471 (100 %) | 4 diff (99.2 %id) | |||
ES309343 | occipital hair of pubic hypotrichosispatient, skin | .e | 152 to 775 | 37 to 651 | I8X K15Q P16A D17G E18R ... | 615/693 (88 %) | 18 diff (97.5 %id) | ||
ES309813 | scalp interfollicular dermis, skin | .e | 150 to 620 | 1 to 471 | 471/471 (100 %) | 2 diff (99.6 %id) | |||
ES311891 | frontal balding hair, skin | .e | 474 to 631 | 1 to 158 | 158/158 (100 %) | 0 diff (100 %id) | |||
GD140460. matches multiple genes | .e | 358 to 438 | 86 to 6 | Submitted on the opposite strand, also hits gene RPS7P1, RPS7P11 | 81/90 (90 %) | 0 diff (100 %id) | |||
GD146741 | .e | 445 to 792 | 5 to 352 | AAA | Possibly primed on the genome, locally A rich (13/15 A in genome downstream of last aligned base) | 348/352 (98 %) | 6 diff (98.3 %id) | ||
GD153833. matches multiple genes | .e | 684 to 787 | 15 to 118 | AAA | Possibly primed on the genome, locally A rich (13/15 A in genome downstream of last aligned base), also hits gene RPS7P1 | 104/118 (88 %) | 6 diff (95.0 %id) | ||
GD158160 | .e | 617 to 792 | 1 to 176 | AAA | Possibly primed on the genome, locally A rich (13/15 A in genome downstream of last aligned base) | 176/176 (100 %) | 4 diff (97.8 %id) | ||
GD159251 | .e | 442 to 509 | 1 to 68 | AAA | Internal priming: the 3' end of the oligo dT primed clone lies in the CDS | 68/69 (98 %) | 4 diff (94.3 %id) | ||
AV653876 | corresponding non cancerous liver tissue | .e | 148 to 789 | 1 to 642 | F173X F187X | AAA | Submitted on the opposite strand | 642/642 (100 %) | 0 diff (100 %id) |
DB461596 | testis | .e | 131 to 618 | 1 to 488 | 488/488 (100 %) | 0 diff (100 %id) | |||
DB527011 | testis | .e | 340 to 789 | 1 to 450 | Submitted on the opposite strand | 450/450 (100 %) | 0 diff (100 %id) | ||
DB476577 | hippocampus | .e | 113 to 610 | 1 to 498 | 498/498 (100 %) | 0 diff (100 %id) | |||
BP385364 | pancreatic islet | .e | 187 to 429 | 245 to 1 | 245/245 (100 %) | 2 diff (99.2 %id) | |||
BP385861 | pancreatic islet | .f | 1212 to 1422 | 16 to 227 | Submitted on the opposite strand | 212/227 (93 %) | 6 diff (97.4 %id) | ||
BQ639468 | eye, retina | .e | 110 to 740 | 1 to 631 | 631/631 (100 %) | 0 diff (100 %id) | |||
BY796232 | eye | .e | 158 to 793 | 1 to 636 | exact | 636/636 (100 %) | 0 diff (100 %id) | ||
BJ991616 | hepatoblastoma | .e | 128 to 636 | 1 to 509 | 509/509 (100 %) | 1 diff (99.9 %id) | |||
BJ995456 | hepatoblastoma | .e | 127 to 558 | 1 to 432 | fully sequenced, | 432/432 (100 %) | 1 diff (99.8 %id) | ||
BJ995457 | hepatoblastoma | .e | 497 to 760 | 264 to 1 | fully sequenced, | 264/264 (100 %) | 0 diff (100 %id) | ||
AV725280 | hypothalamus | .e | 140 to 792 | 1 to 653 | exact | AAA | Possibly primed on the genome, locally A rich (13/15 A in genome downstream of last aligned base) | 653/653 (100 %) | 2 diff (99.7 %id) |
CN484983 | eye | .e | 156 to 786 | 1 to 631 | exact | 631/631 (100 %) | 0 diff (100 %id) | ||
BJ996511 | hepatoblastoma | .e | 188 to 703 | 1 to 516 | 516/516 (100 %) | 3 diff (99.5 %id) | |||
BJ996519 | hepatoblastoma | .e | 128 to 724 | 1 to 597 | 597/597 (100 %) | 0 diff (100 %id) | |||
BJ996630 | hepatoblastoma | .e | 128 to 633 | 1 to 506 | 506/506 (100 %) | 1 diff (99.9 %id) | |||
BJ997040 | hepatoblastoma | .e | 128 to 577 | 1 to 450 | 450/450 (100 %) | 0 diff (100 %id) | |||
AF085824 | .m | 308 to 812 | 1 to 505 | tiling clone, AAA | Possibly primed on the genome, locally A rich (13/15 A in genome downstream of last aligned base) | 505/505 (100 %) | 1 diff (99.9 %id) | ||
R11403 | liver and spleen | .m | 309 to 637 | 1 to 342 | 342/382 (89 %) | 22 diff (94.3 %id) | |||
R19153 | liver and spleen | .i | 1053 to 1380 | 333 to 1 | 333/334 (99 %) | 8 diff (97.7 %id) | |||
H84686 | eye, retina | .i | 993 to 1376 | 391 to 1 | Submitted on the opposite strand | 391/391 (100 %) | 9 diff (97.7 %id) | ||
H85084 | eye, retina | .i | 320 to 612 | 1 to 294 | Submitted on the opposite strand | 294/295 (99 %) | 2 diff (99.4 %id) | ||
H84775 | eye, retina | .i | 320 to 634 | 1 to 318 | Submitted on the opposite strand | 318/318 (100 %) | 5 diff (98.5 %id) | ||
H85395 | eye, retina | .i | 1039 to 1376 | 340 to 1 | Submitted on the opposite strand | 340/343 (99 %) | 5 diff (98.6 %id) | ||
N72809 | liver and spleen | .e | 301 to 428 | 1 to 128 | 128/128 (100 %) | 1 diff (99.3 %id) | |||
N90120 | lung | .e | 432 to 792 | 363 to 1 | fully sequenced, | 363/363 (100 %) | 0 diff (100 %id) | ||
W16739 | lung | .e | 185 to 462 | 1 to 278 | fully sequenced, | 278/278 (100 %) | 0 diff (100 %id) | ||
N93956 | lung | .e | 464 to 789 | 325 to 1 | 325/464 (70 %) | 4 diff (99.2 %id) | |||
AA149141 | .e | 166 to 651 | 1 to 488 | 488/489 (99 %) | 8 diff (98.4 %id) | ||||
AA186954 | .e | 356 to 758 | 1 to 409 | 409/414 (98 %) | 11 diff (97.4 %id) | ||||
AA401942 | ovarian tumor, ovary | .e | 480 to 798 | 319 to 1 | tiling clone, fully sequenced, | 319/319 (100 %) | 1 diff (99.7 %id) | ||
AA402097 | ovarian tumor, ovary | .e | 82 to 510 | 1 to 427 | fully sequenced, | 427/427 (100 %) | 3 diff (99.3 %id) | ||
AA420550 | .e | 293 to 792 | 529 to 30 | AAA | Possibly primed on the genome, locally A rich (13/15 A in genome downstream of last aligned base) | 500/500 (100 %) | 0 diff (100 %id) | ||
AA228409 | .j | 49 to 332 | 284 to 1 | tiling clone, | 284/284 (100 %) | 0 diff (100 %id) | |||
AA588399 | colon, colon tumor RER+ | .n | 633 to 1038 | 1 to 406 | exact | tiling clone, | Submitted on the opposite strand | 406/406 (100 %) | 0 diff (100 %id) |
AA582168 | germ cell tumor | .e | 163 to 792 | 630 to 1 | exact | 630/630 (100 %) | 0 diff (100 %id) | ||
AA654683. matches multiple genes | .e | 158 to 224 | 8 to 74 | also hits gene RPS7P11 | 67/74 (90 %) | 6 diff (91.9 %id) | |||
AA873460 | 2 pooled tumors (clear cell type), Kidney | .e | 164 to 792 | 628 to 1 | S4* | 628/632 (99 %) | 1 diff (99.9 %id) | ||
AA938377 | carcinoid, lung | .f | 1086 to 1424 | 339 to 1 | 339/339 (100 %) | 0 diff (100 %id) | |||
AI356913 | lymph node, lymphoma, follicular mixed small and largecell | .e | 372 to 640 | 269 to 1 | 269/269 (100 %) | 0 diff (100 %id) | |||
AI474692 | colon, moderately-differentiated adenocarcinoma | .f | 1300 to 1424 | 127 to 1 | 127/129 (98 %) | 1 diff (99.3 %id) | |||
AI476623 | colon, moderately-differentiated adenocarcinoma | .e | 286 to 640 | 354 to 1 | 354/354 (100 %) | 1 diff (99.8 %id) | |||
AI570783 | adenocarcinoma, Pancreas | .e | 479 to 640 | 162 to 1 | 162/162 (100 %) | 0 diff (100 %id) | |||
AI707767 | aorta | .g | 193 to 561 | 369 to 1 | tiling clone, | 369/369 (100 %) | 2 diff (99.5 %id) | ||
AI719857 | aorta | .e | 270 to 747 | 477 to 1 | 477/477 (100 %) | 43 diff (91.0 %id) | |||
AI889887 | moderately-differentiated endometrialadenocarcinoma, 3 pooled tumors, uterus | .e | 380 to 640 | 261 to 1 | 261/261 (100 %) | 0 diff (100 %id) | |||
AI978984 | uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors | .e | 277 to 640 | 363 to 1 | 363/363 (100 %) | 1 diff (99.8 %id) | |||
AW088925 | ovary, tumor, 5 pooled (see description) | .e | 553 to 640 | 90 to 1 | 90/90 (100 %) | 2 diff (97.8 %id) | |||
AW102842 | ovary, tumor, 5 pooled (see description) | .e | 296 to 640 | 345 to 1 | 345/345 (100 %) | 1 diff (99.8 %id) | |||
AW263699 | lung, two pooled squamous cell carcinomas | .e | 370 to 640 | 271 to 1 | 271/271 (100 %) | 0 diff (100 %id) | |||
AW327642. matches multiple genes | blood, T cell leukemia | .e | 318 to 792 | 500 to 25 | AAA | Possibly primed on the genome, locally A rich (13/15 A in genome downstream of last aligned base), also hits gene RPS7P1 | 476/476 (100 %) | 4 diff (99.2 %id) | |
AW327366. matches multiple genes | blood, T cell leukemia | .e | 307 to 768 | 27 to 488 | also hits gene RPS7P11 | 462/488 (94 %) | 0 diff (100 %id) | ||
AW327895. matches multiple genes | Burkitt lymphoma, lymph | .e | 113 to 592 | 1 to 480 | also hits gene RPS7P11 | 480/480 (100 %) | 2 diff (99.6 %id) | ||
AW768495 | lymph node, lymphoma, follicular mixed small and largecell | .e | 296 to 640 | 345 to 1 | 345/345 (100 %) | 0 diff (100 %id) | |||
AW768541 | lymph node, lymphoma, follicular mixed small and largecell | .e | 310 to 640 | 331 to 1 | 331/331 (100 %) | 1 diff (99.7 %id) | |||
AW768575 | lymph node, lymphoma, follicular mixed small and largecell | .e | 292 to 640 | 349 to 1 | 349/349 (100 %) | 0 diff (100 %id) | |||
BE298651 | muscle, rhabdomyosarcoma | .e | 168 to 256 | 1 to 89 | 89/89 (100 %) | 0 diff (100 %id) | |||
BE277230 | melanotic melanoma, skin | .e | 160 to 256 | 1 to 97 | 97/97 (100 %) | 0 diff (100 %id) | |||
AW404175 | lymph | .m | 13 to 212 | 7 to 206 | 200/208 (96 %) | 2 diff (99.1 %id) | |||
AW404673. matches multiple genes | lymph | .e | 182 to 707 | 8 to 534 | also hits gene RPS7P11 | 527/534 (98 %) | 1 diff (99.9 %id) | ||
BE348977 | malignant melanoma, metastatic to lymphnode, skin | .e | 292 to 640 | 349 to 1 | 349/349 (100 %) | 2 diff (99.5 %id) | |||
BE349026 | malignant melanoma, metastatic to lymphnode, skin | .e | 280 to 640 | 361 to 1 | 361/361 (100 %) | 0 diff (100 %id) | |||
BE263050 | brain, neuroblastoma | .e | 164 to 256 | 1 to 93 | 93/93 (100 %) | 0 diff (100 %id) | |||
BE259674 | brain, neuroblastoma | .e | 164 to 257 | 1 to 95 | 95/95 (100 %) | 1 diff (99.0 %id) | |||
BE312133 | brain, neuroblastoma | .e | 164 to 256 | 1 to 93 | 93/93 (100 %) | 0 diff (100 %id) | |||
BE262379 | brain, neuroblastoma | .e | 162 to 256 | 1 to 95 | 95/95 (100 %) | 0 diff (100 %id) | |||
BF061102 | fibrotheoma, ovary | .n | 1 to 572 | 572 to 1 | tiling clone, | 572/572 (100 %) | 1 diff (99.9 %id) | ||
BE312225 | brain, neuroblastoma | .e | 165 to 256 | 1 to 92 | 92/92 (100 %) | 0 diff (100 %id) | |||
BE295749 | muscle, rhabdomyosarcoma | .e | 177 to 256 | 1 to 80 | 80/80 (100 %) | 0 diff (100 %id) | |||
BE264305 | lung, small cell carcinoma | .e | 169 to 256 | 1 to 88 | 88/88 (100 %) | 0 diff (100 %id) | |||
BE264581 | lung, small cell carcinoma | .e | 168 to 247 | 1 to 80 | 80/89 (89 %) | 2 diff (97.8 %id) | |||
BE264070 | lung, small cell carcinoma | .e | 166 to 256 | 1 to 91 | 91/91 (100 %) | 0 diff (100 %id) | |||
BE512765 | adenocarcinoma cell line, colon | .e | 163 to 256 | 1 to 94 | 94/94 (100 %) | 0 diff (100 %id) | |||
BE278045 | choriocarcinoma, placenta | .e | 169 to 256 | 1 to 88 | 88/88 (100 %) | 0 diff (100 %id) | |||
BE378829 | endometrium, adenocarcinoma cell line, uterus | .e | 169 to 256 | 1 to 88 | 88/88 (100 %) | 0 diff (100 %id) | |||
BE615645 | adenocarcinoma, Pancreas | .e | 162 to 256 | 1 to 95 | 95/95 (100 %) | 0 diff (100 %id) | |||
BE616042 | adenocarcinoma, Pancreas | .d | 41 to 670 | 1 to 629 | F63L V64F V66F P67L Q68N ... | 629/629 (100 %) | 3 diff (99.6 %id) | ||
BE385304 | melanotic melanoma, skin | .e | 166 to 256 | 1 to 91 | 91/91 (100 %) | 0 diff (100 %id) | |||
BE382890 | brain, neuroblastoma | .e | 181 to 256 | 1 to 76 | 76/76 (100 %) | 0 diff (100 %id) | |||
BE382935 | brain, neuroblastoma | .e | 166 to 256 | 1 to 91 | 91/91 (100 %) | 0 diff (100 %id) | |||
BE392515 | endometrium, adenocarcinoma cell line, uterus | .e | 167 to 256 | 1 to 90 | 90/90 (100 %) | 0 diff (100 %id) | |||
BE619933 | large cell carcinoma, lung | .e | 165 to 704 | 541 to 1 | 541/541 (100 %) | 2 diff (99.7 %id) | |||
BE743833 | adenocarcinoma cell line, ovary | .e | 168 to 786 | 1 to 619 | exact | 619/619 (100 %) | 0 diff (100 %id) | ||
BE740306 | adenocarcinoma cell line, ovary | .e | 159 to 256 | 1 to 98 | 98/98 (100 %) | 0 diff (100 %id) | |||
BE898805 | adenocarcinoma cell line, ovary | .e | 163 to 256 | 1 to 94 | 94/94 (100 %) | 0 diff (100 %id) | |||
BF316874 | brain, neuroblastoma | .e | 146 to 794 | 1 to 652 | exact | 652/674 (96 %) | 10 diff (98.6 %id) | ||
BG230896 | well-differentiated invasive carcinoma,floor of mouth | .i | 1972 to 2258 | 310 to 23 | AAA | Possibly primed on the genome, locally A rich (13/15 A in genome downstream of last aligned base) | 288/306 (94 %) | 4 diff (98.7 %id) | |
BF694011 | muscle (skeletal) | .b | 34 to 537 | 1 to 505 | 505/505 (100 %) | 9 diff (98.3 %id) | |||
BF666650 | brain, primitive neuroectoderm | .a | 1 to 704 | 1 to 697 | E131G D132G V134G F135L S137K ... | tiling clone, | 697/747 (93 %) | 15 diff (98.0 %id) | |
BF668082 | brain, primitive neuroectoderm | .b | 24 to 713 | 1 to 680 | 680/832 (81 %) | 21 diff (97.5 %id) | |||
BF663487 | B-cells, primary B-cells from tonsils (cell line) | .e | 157 to 276 | 1 to 120 | 120/120 (100 %) | 1 diff (99.2 %id) | |||
BF688651 | eye, normal pigmented retinal epithelium | .e | 158 to 276 | 1 to 119 | 119/119 (100 %) | 1 diff (99.2 %id) | |||
BF973971 | leiomyosarcoma cell line, uterus | .e | 157 to 276 | 1 to 120 | 120/120 (100 %) | 1 diff (99.2 %id) | |||
BF974206 | B-cells, primary B-cells from tonsils (cell line) | .d | 32 to 672 | 1 to 640 | L83W E84R K86S F87S S88V ... | tiling clone, AAA | Possibly primed on the genome, locally A rich (13/15 A in genome downstream of last aligned base) | 640/640 (100 %) | 2 diff (99.7 %id) |
BF793343 | adrenal cortex carcinoma, cell line, adrenal gland | .e | 157 to 794 | 1 to 664 | E14D K15E P16C D17R E18T ... | 661/683 (96 %) | 38 diff (94.5 %id) | ||
BG107755 | Bone, osteosarcoma, cell line | .d | 39 to 673 | 1 to 638 | K155T V156G H157S L158F D159G ... | 638/664 (96 %) | 15 diff (97.8 %id) | ||
BG106711 | lymph, lymphoma, cell line | .e | 140 to 793 | 1 to 655 | exact | 655/670 (97 %) | 2 diff (99.8 %id) | ||
BG107391 | lymph, lymphoma, cell line | .e | 145 to 792 | 1 to 648 | exact | AAA | Possibly primed on the genome, locally A rich (13/15 A in genome downstream of last aligned base) | 648/648 (100 %) | 0 diff (100 %id) |
BG032854 | breast, mammary adenocarcinoma, cell line | .e | 143 to 793 | 1 to 654 | L194F | 654/668 (97 %) | 9 diff (98.7 %id) | ||
BG168235 | hypernephroma, cell line, Kidney | .e | 149 to 787 | 1 to 636 | exact | AAA | Possibly primed on the genome, locally A rich (13/15 A in genome downstream of last aligned base) | 636/639 (99 %) | 4 diff (99.4 %id) |
BG164895 | hypernephroma, cell line, Kidney | .e | 148 to 787 | 1 to 642 | exact | 642/901 (71 %) | 8 diff (99.2 %id) | ||
BG254801 | adenocarcinoma, cell line, Prostate | .e | 156 to 792 | 1 to 638 | exact | AAA | Possibly primed on the genome, locally A rich (13/15 A in genome downstream of last aligned base) | 638/638 (100 %) | 1 diff (99.9 %id) |
BG391935 | embryonal carcinoma, cell line, testis | .e | 149 to 793 | 1 to 644 | exact | 644/729 (88 %) | 2 diff (99.8 %id) | ||
BG575234 | breast, mammary adenocarcinoma, cell line | .e | 149 to 792 | 1 to 644 | exact | AAA | Possibly primed on the genome, locally A rich (13/15 A in genome downstream of last aligned base) | 644/644 (100 %) | 0 diff (100 %id) |
BG686258 | B-cells, primary B-cells from tonsils (cell line) | .a | 90 to 721 | 1 to 632 | exact | tiling clone, AAA | Possibly primed on the genome, locally A rich (13/15 A in genome downstream of last aligned base) | 632/632 (100 %) | 0 diff (100 %id) |
BG686245 | B-cells, primary B-cells from tonsils (cell line) | .e | 144 to 792 | 1 to 649 | exact | AAA | Possibly primed on the genome, locally A rich (13/15 A in genome downstream of last aligned base) | 649/649 (100 %) | 0 diff (100 %id) |
BG760316 | melanotic melanoma, high MDR (cell line), skin | .d | 37 to 672 | 1 to 636 | K178X | AAA | Possibly primed on the genome, locally A rich (13/15 A in genome downstream of last aligned base) | 636/636 (100 %) | 0 diff (100 %id) |
BG759473 | B-cells, primary B-cells from tonsils (cell line) | .e | 150 to 276 | 1 to 127 | 127/127 (100 %) | 4 diff (96.9 %id) | |||
BG756567 | B-cells, primary B-cells from tonsils (cell line) | .e | 144 to 792 | 1 to 649 | exact | AAA | Possibly primed on the genome, locally A rich (13/15 A in genome downstream of last aligned base) | 649/649 (100 %) | 0 diff (100 %id) |
BG763895 | melanotic melanoma, high MDR (cell line), skin | .e | 162 to 276 | 1 to 115 | 115/115 (100 %) | 0 diff (100 %id) | |||
BG766416 | melanotic melanoma, high MDR (cell line), skin | .e | 162 to 276 | 1 to 115 | 115/115 (100 %) | 0 diff (100 %id) | |||
BG767456 | melanotic melanoma, high MDR (cell line), skin | .e | 157 to 276 | 1 to 120 | 120/120 (100 %) | 1 diff (99.2 %id) | |||
BG751892 | eye, normal pigmented retinal epithelium | .e | 162 to 276 | 1 to 115 | 115/115 (100 %) | 0 diff (100 %id) | |||
BG759920 | B-cells, primary B-cells from tonsils (cell line) | .a | 90 to 722 | 1 to 634 | exact | 634/654 (96 %) | 2 diff (99.7 %id) | ||
BI196365 | brain, neuroblastoma | .i | 8 to 357 | 1 to 348 | 348/348 (100 %) | 3 diff (99.2 %id) | |||
BI710836. matches multiple genes | insulinoma, Pancreas | .e | 156 to 732 | 1 to 577 | also hits gene RPS7P11 | 577/577 (100 %) | 10 diff (98.3 %id) | ||
BI258839 | cervical carcinoma cell line, cervix | .e | 149 to 793 | 1 to 645 | exact | 645/661 (97 %) | 1 diff (99.9 %id) | ||
BI828213 | brain, medulla | .e | 147 to 793 | 1 to 647 | exact | 647/708 (91 %) | 1 diff (99.9 %id) | ||
BI763908 | pooled colon, kidney, stomach | .e | 156 to 792 | 1 to 638 | exact | AAA | Possibly primed on the genome, locally A rich (13/15 A in genome downstream of last aligned base) | 638/638 (100 %) | 1 diff (99.9 %id) |
BI522464 | brain | .m | 12 to 823 | 1 to 812 | exact | tiling clone, | 812/812 (100 %) | 3 diff (99.7 %id) | |
BI858665 | breast, mammary adenocarcinoma, cell line | .e | 145 to 792 | 1 to 648 | exact | AAA | Possibly primed on the genome, locally A rich (13/15 A in genome downstream of last aligned base) | 648/648 (100 %) | 0 diff (100 %id) |
BI869125 | adenocarcinoma, cell line, Liver | .d | 41 to 645 | 1 to 609 | E84D K85E K86T F87S G89V ... | 609/803 (75 %) | 13 diff (98.4 %id) | ||
BM014024 | breast, mammary adenocarcinoma, cell line | .e | 130 to 793 | 1 to 664 | exact | 664/683 (97 %) | 2 diff (99.8 %id) | ||
BM050096 | epithelioid carcinoma cell line, Pancreas | .e | 168 to 276 | 1 to 109 | 109/109 (100 %) | 1 diff (99.1 %id) | |||
BM549670 | astrocytoma grade IV, cell line, brain | .e | 144 to 792 | 28 to 676 | exact | AAA | Possibly primed on the genome, locally A rich (13/15 A in genome downstream of last aligned base) | 649/676 (96 %) | 0 diff (100 %id) |
BM043379 | carcinoma, cell line, Prostate | .e | 147 to 792 | 2 to 647 | exact | AAA | Possibly primed on the genome, locally A rich (13/15 A in genome downstream of last aligned base) | 646/647 (99 %) | 0 diff (100 %id) |
BM811121 | amelanotic melanoma, cell line, skin | .e | 145 to 787 | 1 to 643 | exact | AAA | 643/648 (99 %) | 2 diff (99.7 %id) | |
BM914098 | astrocytoma grade IV, cell line, brain | .e | 149 to 792 | 1 to 644 | exact | AAA | Possibly primed on the genome, locally A rich (13/15 A in genome downstream of last aligned base) | 644/644 (100 %) | 0 diff (100 %id) |
BM562593 | amelanotic melanoma, cell line, skin | .d | 41 to 672 | 1 to 632 | F135C | AAA | Possibly primed on the genome, locally A rich (13/15 A in genome downstream of last aligned base) | 632/632 (100 %) | 2 diff (99.7 %id) |
BM803869 | leiomyosarcoma, uterus | .e | 146 to 792 | 1 to 647 | exact | AAA | Possibly primed on the genome, locally A rich (13/15 A in genome downstream of last aligned base) | 647/647 (100 %) | 2 diff (99.7 %id) |
BM449498 | leiomyosarcoma, uterus | .e | 158 to 792 | 1 to 635 | exact | AAA | Possibly primed on the genome, locally A rich (13/15 A in genome downstream of last aligned base) | 635/635 (100 %) | 0 diff (100 %id) |
BM542406 | melanotic melanoma, skin | .e | 141 to 792 | 29 to 680 | exact | AAA | Possibly primed on the genome, locally A rich (13/15 A in genome downstream of last aligned base) | 652/680 (95 %) | 3 diff (99.6 %id) |
BM469144 | duodenal adenocarcinoma, cell line, small intestine | .e | 145 to 793 | 1 to 649 | exact | 649/653 (99 %) | 1 diff (99.9 %id) | ||
BM477495 | lymph, lymphoma, cell line | .i | 2656 to 3506 | 1 to 861 | AAA | 861/1085 (79 %) | 19 diff (98.3 %id) | ||
BM802724 | embryonal carcinoma, cell line, testis | .e | 128 to 786 | 1 to 660 | exact | AAA | 660/667 (98 %) | 2 diff (99.8 %id) | |
BM470372 | eye, retinoblastoma | .e | 149 to 792 | 1 to 644 | exact | AAA | Possibly primed on the genome, locally A rich (13/15 A in genome downstream of last aligned base) | 644/644 (100 %) | 0 diff (100 %id) |
BM475976 | eye, retinoblastoma | .e | 147 to 792 | 13 to 658 | exact | AAA | Possibly primed on the genome, locally A rich (13/15 A in genome downstream of last aligned base) | 646/658 (98 %) | 0 diff (100 %id) |
BM876446. matches multiple genes | insulinoma, Pancreas | .e | 158 to 689 | 8 to 539 | also hits gene RPS7P11 | 532/540 (98 %) | 7 diff (98.8 %id) | ||
BM546813 | ovary (pool of 3) | .f | 1 to 1007 | 28 to 1043 | R143S K155R V156F H157I A161H ... | tiling clone, | 1022/1058 (96 %) | 39 diff (96.4 %id) | |
BM907733 | large cell carcinoma, lung | .e | 146 to 792 | 1 to 647 | exact | AAA | Possibly primed on the genome, locally A rich (13/15 A in genome downstream of last aligned base) | 647/647 (100 %) | 0 diff (100 %id) |
BM907859 | large cell carcinoma, lung | .e | 131 to 792 | 1 to 662 | exact | AAA | Possibly primed on the genome, locally A rich (13/15 A in genome downstream of last aligned base) | 662/662 (100 %) | 0 diff (100 %id) |
BM556835 | duodenal adenocarcinoma, cell line, small intestine | .e | 156 to 790 | 1 to 635 | exact | 635/640 (99 %) | 1 diff (99.9 %id) | ||
BQ222389 | large cell carcinoma, lung | .e | 150 to 792 | 1 to 643 | exact | AAA | Possibly primed on the genome, locally A rich (13/15 A in genome downstream of last aligned base) | 643/643 (100 %) | 0 diff (100 %id) |
BQ286487. matches multiple genes | Pancreas, Purified pancreatic islet | .e | 240 to 753 | 1 to 514 | also hits gene RPS7P1 | 514/514 (100 %) | 1 diff (99.9 %id) | ||
BQ270020. matches multiple genes | Pancreas, Purified pancreatic islet | .e | 153 to 576 | 1 to 424 | also hits gene RPS7P1 | 424/424 (100 %) | 0 diff (100 %id) | ||
BQ270158. matches multiple genes | Pancreas, Purified pancreatic islet | .e | 155 to 753 | 7 to 605 | also hits gene RPS7P11 | 599/605 (99 %) | 6 diff (99.1 %id) | ||
BQ286672 | Pancreas, Purified pancreatic islet | .e | 199 to 791 | 593 to 1 | 593/593 (100 %) | 5 diff (99.2 %id) | |||
BQ287910 | Pancreas, Purified pancreatic islet | .e | 181 to 791 | 611 to 1 | 611/611 (100 %) | 0 diff (100 %id) | |||
BQ056638 | lymph, lymphoma, cell line | .e | 149 to 787 | 1 to 639 | exact | AAA | 639/644 (99 %) | 1 diff (99.9 %id) | |
BQ059453 | lymph, lymphoma, cell line | .e | 150 to 790 | 1 to 641 | exact | 641/643 (99 %) | 1 diff (99.9 %id) | ||
BQ008476 | Chondrosarcoma, Left Pubic Bone | .e | 75 to 792 | 735 to 19 | exact | AAA | Possibly primed on the genome, locally A rich (13/15 A in genome downstream of last aligned base) | 717/727 (98 %) | 1 diff (99.9 %id) |
BQ005859 | Chondrosarcoma, Left Pubic Bone | .e | 152 to 792 | 659 to 19 | exact | AAA | Possibly primed on the genome, locally A rich (13/15 A in genome downstream of last aligned base) | 641/652 (98 %) | 0 diff (100 %id) |
BQ061967 | lymph, lymphoma, cell line | .e | 121 to 792 | 1 to 672 | exact | AAA | Possibly primed on the genome, locally A rich (13/15 A in genome downstream of last aligned base) | 672/672 (100 %) | 0 diff (100 %id) |
BQ070930 | brain, neuroblastoma, cell line | .e | 100 to 792 | 1 to 693 | exact | AAA | Possibly primed on the genome, locally A rich (13/15 A in genome downstream of last aligned base) | 693/693 (100 %) | 0 diff (100 %id) |
BQ064052 | lymph, lymphoma, cell line | .e | 145 to 792 | 1 to 648 | exact | AAA | Possibly primed on the genome, locally A rich (13/15 A in genome downstream of last aligned base) | 648/648 (100 %) | 0 diff (100 %id) |
BQ064055 | lymph, lymphoma, cell line | .e | 144 to 792 | 17 to 665 | exact | AAA | Possibly primed on the genome, locally A rich (13/15 A in genome downstream of last aligned base) | 649/665 (97 %) | 6 diff (99.1 %id) |
BQ071838 | brain, neuroblastoma, cell line | .e | 100 to 792 | 1 to 695 | exact | 695/1102 (63 %) | 3 diff (99.8 %id) | ||
BQ072031 | brain, neuroblastoma, cell line | .e | 150 to 791 | 1 to 642 | exact | AAA | Possibly primed on the genome, locally A rich (13/15 A in genome downstream of last aligned base) | 642/644 (99 %) | 1 diff (99.9 %id) |
BQ052999 | blood, natural killer cells, cell line | .e | 145 to 792 | 1 to 648 | exact | AAA | Possibly primed on the genome, locally A rich (13/15 A in genome downstream of last aligned base) | 648/648 (100 %) | 0 diff (100 %id) |
BU157063 | hepatocellular carcinoma, cell line, Liver | .e | 149 to 792 | 1 to 644 | exact | AAA | Possibly primed on the genome, locally A rich (13/15 A in genome downstream of last aligned base) | 644/644 (100 %) | 0 diff (100 %id) |
BU191904 | large cell carcinoma, lung | .e | 146 to 792 | 1 to 647 | exact | 647/647 (100 %) | 1 diff (99.9 %id) | ||
BQ227914 | epithelioid carcinoma, Pancreas | .e | 144 to 792 | 1 to 649 | exact | AAA | Possibly primed on the genome, locally A rich (13/15 A in genome downstream of last aligned base) | 649/649 (100 %) | 0 diff (100 %id) |
BQ224895 | epithelioid carcinoma, Pancreas | .e | 147 to 792 | 12 to 657 | exact | AAA | Possibly primed on the genome, locally A rich (13/15 A in genome downstream of last aligned base) | 646/657 (98 %) | 0 diff (100 %id) |
BU163957 | large cell carcinoma, lung | .e | 143 to 792 | 1 to 650 | exact | AAA | Possibly primed on the genome, locally A rich (13/15 A in genome downstream of last aligned base) | 650/650 (100 %) | 0 diff (100 %id) |
BQ632149 | Pancreas, Purified pancreatic islet | .e | 178 to 793 | 618 to 3 | 616/618 (99 %) | 0 diff (100 %id) | |||
BQ631730. matches multiple genes | Pancreas, Purified pancreatic islet | .e | 152 to 753 | 7 to 608 | also hits gene RPS7P11 | 602/608 (99 %) | 6 diff (99.1 %id) | ||
BQ776705 | Pancreas, Purified pancreatic islet | .e | 172 to 791 | 620 to 1 | exact | 620/620 (100 %) | 0 diff (100 %id) | ||
BU076356 | Pancreas, Purified pancreatic islet | .e | 497 to 791 | 295 to 1 | fully sequenced, | 295/295 (100 %) | 0 diff (100 %id) | ||
BU076639 | Pancreas, Purified pancreatic islet | .e | 155 to 775 | 1 to 621 | exact | fully sequenced, | 621/621 (100 %) | 0 diff (100 %id) | |
BQ224471 | embryonal carcinoma, cell line, testis | .e | 157 to 793 | 1 to 637 | exact | 637/923 (69 %) | 1 diff (99.9 %id) | ||
BQ221532 | large cell carcinoma, lung | .e | 159 to 792 | 1 to 635 | exact | AAA | Possibly primed on the genome, locally A rich (13/15 A in genome downstream of last aligned base) | 635/635 (100 %) | 1 diff (99.9 %id) |
BQ215624 | large cell carcinoma, lung | .e | 146 to 792 | 1 to 647 | exact | AAA | Possibly primed on the genome, locally A rich (13/15 A in genome downstream of last aligned base) | 647/647 (100 %) | 0 diff (100 %id) |
BQ217892 | large cell carcinoma, lung | .e | 144 to 789 | 1 to 646 | exact | AAA | Possibly primed on the genome, locally A rich (13/15 A in genome downstream of last aligned base) | 646/646 (100 %) | 0 diff (100 %id) |
BQ212258 | large cell carcinoma, lung | .e | 164 to 792 | 1 to 629 | exact | 629/633 (99 %) | 1 diff (99.9 %id) | ||
BQ888400 | melanotic melanoma, cell line, skin | .e | 154 to 792 | 1 to 639 | exact | AAA | Possibly primed on the genome, locally A rich (13/15 A in genome downstream of last aligned base) | 639/639 (100 %) | 0 diff (100 %id) |
BU156850 | melanotic melanoma, cell line, skin | .e | 154 to 792 | 1 to 639 | exact | AAA | Possibly primed on the genome, locally A rich (13/15 A in genome downstream of last aligned base) | 639/639 (100 %) | 0 diff (100 %id) |
BU948899 | Pancreas, Purified pancreatic islet | .e | 194 to 753 | 1 to 560 | 560/560 (100 %) | 2 diff (99.7 %id) | |||
BU948854. matches multiple genes | Pancreas, Purified pancreatic islet | .e | 182 to 753 | 1 to 572 | also hits gene RPS7P1 | 572/572 (100 %) | 0 diff (100 %id) | ||
BU789908. matches multiple genes | insulinoma, Pancreas | .e | 158 to 753 | 8 to 603 | also hits gene RPS7P11 | 596/603 (98 %) | 7 diff (98.9 %id) | ||
BU176333 | eye, retinoblastoma | .e | 150 to 793 | 1 to 644 | exact | 644/648 (99 %) | 1 diff (99.9 %id) | ||
BU159507 | eye, retinoblastoma | .e | 150 to 793 | 1 to 644 | exact | 644/644 (100 %) | 0 diff (100 %id) | ||
BU165520 | eye, retinoblastoma | .e | 160 to 792 | 1 to 633 | exact | AAA | Possibly primed on the genome, locally A rich (13/15 A in genome downstream of last aligned base) | 633/633 (100 %) | 0 diff (100 %id) |
BU183069 | melanotic melanoma, skin | .e | 152 to 787 | 1 to 636 | exact | AAA | Possibly primed on the genome, locally A rich (13/15 A in genome downstream of last aligned base) | 636/636 (100 %) | 0 diff (100 %id) |
BQ437700 | melanotic melanoma, skin | .e | 131 to 792 | 1 to 662 | exact | AAA | Possibly primed on the genome, locally A rich (13/15 A in genome downstream of last aligned base) | 662/662 (100 %) | 0 diff (100 %id) |
BU183808 | melanotic melanoma, skin | .e | 142 to 793 | 5 to 656 | exact | 652/659 (98 %) | 1 diff (99.9 %id) | ||
BU189613 | eye, retinoblastoma | .d | 41 to 651 | 1 to 611 | exact | AAA | Internal priming: the 3' end of the oligo dT primed clone lies in the CDS | 611/613 (99 %) | 5 diff (99.2 %id) |
BQ722116 | sympathetic trunk | .e | 159 to 793 | 1 to 635 | exact | 635/639 (99 %) | 1 diff (99.9 %id) | ||
BQ932513 | sciatic nerve | .e | 163 to 792 | 1 to 630 | exact | AAA | Possibly primed on the genome, locally A rich (13/15 A in genome downstream of last aligned base) | 630/630 (100 %) | 0 diff (100 %id) |
BQ686456 | ductal carcinoma, cell line, Pancreas | .e | 152 to 793 | 8 to 649 | exact | 642/654 (98 %) | 7 diff (99.0 %id) | ||
BQ677971 | melanotic melanoma, cell line, skin | .e | 149 to 792 | 1 to 644 | exact | AAA | Possibly primed on the genome, locally A rich (13/15 A in genome downstream of last aligned base) | 644/644 (100 %) | 0 diff (100 %id) |
CA776335 | Pancreas, Purified pancreatic islet | .e | 177 to 791 | 615 to 1 | 615/615 (100 %) | 0 diff (100 %id) | |||
CA842100. matches multiple genes | Pancreas, Purified pancreatic islet | .e | 238 to 753 | 1 to 516 | also hits gene RPS7P1 | 516/516 (100 %) | 0 diff (100 %id) | ||
BQ690566 | ductal carcinoma, cell line, Pancreas | .b | 53 to 763 | 1 to 711 | exact | tiling clone, AAA | Possibly primed on the genome, locally A rich (13/15 A in genome downstream of last aligned base) | 711/711 (100 %) | 1 diff (99.9 %id) |
BQ669788 | epidermoid carcinoma, cell line, salivary gland | .d | 41 to 672 | 1 to 632 | exact | AAA | Possibly primed on the genome, locally A rich (13/15 A in genome downstream of last aligned base) | 632/632 (100 %) | 0 diff (100 %id) |
BQ683993 | melanotic melanoma, cell line, skin | .e | 149 to 792 | 1 to 644 | exact | AAA | Possibly primed on the genome, locally A rich (13/15 A in genome downstream of last aligned base) | 644/644 (100 %) | 0 diff (100 %id) |
BQ684459 | melanotic melanoma, cell line, skin | .e | 91 to 787 | 1 to 697 | Q193P | 697/997 (69 %) | 4 diff (99.6 %id) | ||
BQ680094 | melanotic melanoma, cell line, skin | .e | 154 to 792 | 1 to 639 | exact | AAA | Possibly primed on the genome, locally A rich (13/15 A in genome downstream of last aligned base) | 639/639 (100 %) | 0 diff (100 %id) |
BQ681002 | melanotic melanoma, cell line, skin | .e | 154 to 792 | 1 to 639 | exact | AAA | Possibly primed on the genome, locally A rich (13/15 A in genome downstream of last aligned base) | 639/639 (100 %) | 0 diff (100 %id) |
BQ681998 | melanotic melanoma, cell line, skin | .e | 150 to 787 | 1 to 638 | exact | 638/638 (100 %) | 0 diff (100 %id) | ||
BQ683416 | melanotic melanoma, cell line, skin | .d | 41 to 669 | 1 to 629 | exact | AAA | Possibly primed on the genome, locally A rich (13/15 A in genome downstream of last aligned base) | 629/629 (100 %) | 0 diff (100 %id) |
BU839342 | melanotic melanoma, cell line, skin | .e | 150 to 786 | 1 to 637 | exact | 637/666 (95 %) | 1 diff (99.9 %id) | ||
BQ683072 | melanotic melanoma, cell line, skin | .e | 150 to 788 | 1 to 639 | exact | 639/665 (96 %) | 1 diff (99.9 %id) | ||
BQ646704 | hepatocellular carcinoma, cell line, Liver | .e | 149 to 792 | 1 to 644 | exact | AAA | Possibly primed on the genome, locally A rich (13/15 A in genome downstream of last aligned base) | 644/644 (100 %) | 0 diff (100 %id) |
BQ645396 | hepatocellular carcinoma, cell line, Liver | .d | 41 to 672 | 1 to 632 | K183Q | AAA | Possibly primed on the genome, locally A rich (13/15 A in genome downstream of last aligned base) | 632/632 (100 %) | 4 diff (99.4 %id) |
BQ673214 | epidermoid carcinoma, cell line, salivary gland | .e | 142 to 792 | 1 to 651 | exact | AAA | Possibly primed on the genome, locally A rich (13/15 A in genome downstream of last aligned base) | 651/651 (100 %) | 0 diff (100 %id) |
BQ674366 | epidermoid carcinoma, cell line, salivary gland | .e | 142 to 792 | 1 to 651 | exact | AAA | Possibly primed on the genome, locally A rich (13/15 A in genome downstream of last aligned base) | 651/651 (100 %) | 0 diff (100 %id) |
BQ654312 | hepatocellular carcinoma, cell line, Liver | .e | 149 to 792 | 1 to 644 | exact | AAA | Possibly primed on the genome, locally A rich (13/15 A in genome downstream of last aligned base) | 644/644 (100 %) | 0 diff (100 %id) |
BQ901091 | hepatocellular carcinoma, cell line, Liver | .e | 142 to 792 | 1 to 651 | exact | AAA | Possibly primed on the genome, locally A rich (13/15 A in genome downstream of last aligned base) | 651/651 (100 %) | 0 diff (100 %id) |
BQ898602 | lymph, lymphoma, cell line | .e | 149 to 792 | 1 to 644 | exact | AAA | Possibly primed on the genome, locally A rich (13/15 A in genome downstream of last aligned base) | 644/644 (100 %) | 0 diff (100 %id) |
BU501485 | brain, neuroblastoma, cell line | .e | 100 to 792 | 1 to 693 | exact | 693/932 (74 %) | 2 diff (99.8 %id) | ||
BQ935881 | large cell carcinoma, lung | .e | 132 to 792 | 1 to 661 | exact | AAA | Possibly primed on the genome, locally A rich (13/15 A in genome downstream of last aligned base) | 661/661 (100 %) | 0 diff (100 %id) |
BQ956492 | large cell carcinoma, lung | .e | 152 to 792 | 1 to 641 | exact | AAA | Possibly primed on the genome, locally A rich (13/15 A in genome downstream of last aligned base) | 641/641 (100 %) | 0 diff (100 %id) |
BQ955188 | large cell carcinoma, lung | .e | 162 to 789 | 1 to 628 | exact | AAA | Possibly primed on the genome, locally A rich (13/15 A in genome downstream of last aligned base) | 628/628 (100 %) | 0 diff (100 %id) |
BQ943066 | large cell carcinoma, lung | .e | 149 to 792 | 1 to 644 | exact | AAA | Possibly primed on the genome, locally A rich (13/15 A in genome downstream of last aligned base) | 644/644 (100 %) | 0 diff (100 %id) |
BQ932635 | large cell carcinoma, lung | .e | 162 to 792 | 1 to 631 | exact | AAA | Possibly primed on the genome, locally A rich (13/15 A in genome downstream of last aligned base) | 631/631 (100 %) | 0 diff (100 %id) |
BQ929365 | epidermoid carcinoma, cell line, lung | .e | 149 to 792 | 1 to 644 | exact | AAA | Possibly primed on the genome, locally A rich (13/15 A in genome downstream of last aligned base) | 644/644 (100 %) | 0 diff (100 %id) |
BU506749 | mixed (pool of 40 RNAs) | .b | 123 to 651 | 1 to 533 | 533/937 (56 %) | 9 diff (99.1 %id) | |||
BU507039 | leiomyosarcoma, uterus | .e | 79 to 792 | 1 to 714 | exact | 714/714 (100 %) | 1 diff (99.9 %id) | ||
BU521515 | leiomyosarcoma, uterus | .e | 147 to 792 | 12 to 657 | exact | AAA | Possibly primed on the genome, locally A rich (13/15 A in genome downstream of last aligned base) | 646/657 (98 %) | 0 diff (100 %id) |
CA941850. matches multiple genes | Pancreas, Purified pancreatic islet | .e | 187 to 793 | 611 to 5 | also hits gene RPS7P1 | 607/611 (99 %) | 0 diff (100 %id) | ||
CA941805 | Pancreas, Purified pancreatic islet | .e | 497 to 792 | 296 to 1 | fully sequenced, | 296/296 (100 %) | 0 diff (100 %id) | ||
CA941981 | Pancreas, Purified pancreatic islet | .e | 240 to 774 | 1 to 535 | fully sequenced, | 535/535 (100 %) | 0 diff (100 %id) | ||
BU533085 | mixed (pool of 40 RNAs) | .e | 125 to 793 | 1 to 668 | E188* | 668/674 (99 %) | 3 diff (99.6 %id) | ||
BU534073 | mixed (pool of 40 RNAs) | .b | 21 to 575 | 1 to 566 | 566/1040 (54 %) | 19 diff (98.2 %id) | |||
BU553728 | ovary, teratocarcinoma, cell line | .e | 152 to 793 | 1 to 642 | exact | AAA | Possibly primed on the genome, locally A rich (13/15 A in genome downstream of last aligned base) | 642/644 (99 %) | 1 diff (99.9 %id) |
BU558145 | adenocarcinoma, cell line, breast | .e | 136 to 789 | 1 to 654 | exact | AAA | Possibly primed on the genome, locally A rich (13/15 A in genome downstream of last aligned base) | 654/654 (100 %) | 0 diff (100 %id) |
BU849995 | ovary, teratocarcinoma, cell line | .e | 112 to 791 | 1 to 680 | exact | 680/700 (97 %) | 1 diff (99.9 %id) | ||
CA942820. matches multiple genes | Pancreas, Purified pancreatic islet | .e | 130 to 748 | 10 to 627 | also hits gene RPS7P11 | 618/627 (98 %) | 1 diff (99.9 %id) | ||
CA942868. matches multiple genes | Pancreas, Purified pancreatic islet | .e | 155 to 753 | 1 to 599 | also hits gene RPS7P11 | 599/599 (100 %) | 2 diff (99.7 %id) | ||
CA868564. matches multiple genes | Pancreas, Purified pancreatic islet | .e | 211 to 793 | 586 to 4 | also hits gene RPS7P1 | 583/586 (99 %) | 0 diff (100 %id) | ||
BU934981 | mixed (pool of 40 RNAs) | .i | 2499 to 3291 | 1 to 795 | tiling clone, | 795/797 (99 %) | 8 diff (99.0 %id) | ||
BU941853 | mixed (pool of 40 RNAs) | .e | 33 to 678 | 1 to 647 | tiling clone, AAA | 647/752 (86 %) | 5 diff (99.4 %id) | ||
CX784239 | human embryonic stem cells | .f | 277 to 972 | 1 to 696 | 696/696 (100 %) | 0 diff (100 %id) | |||
CV801755 | Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass | .e | 144 to 793 | 1 to 646 | Q193H L194C | 646/828 (78 %) | 5 diff (99.4 %id) | ||
CB594656 | Blood, promyelocytic leukemia | .e | 81 to 792 | 1 to 712 | exact | AAA | Possibly primed on the genome, locally A rich (13/15 A in genome downstream of last aligned base) | 712/712 (100 %) | 0 diff (100 %id) |
CD109217 | brain, Pituitary | .e | 150 to 792 | 1 to 643 | exact | AAA | Possibly primed on the genome, locally A rich (13/15 A in genome downstream of last aligned base) | 643/643 (100 %) | 0 diff (100 %id) |
CD641774 | pooled | .b | 87 to 747 | 1 to 660 | E171X N186Y F187X E188* | 660/660 (100 %) | 6 diff (99.1 %id) | ||
CK126125 | embryonic stem cell, Embryonic stem cell, pooled H7 ES cell line,passage 22 | .e | 130 to 792 | 25 to 686 | exact | AAA | Possibly primed on the genome, locally A rich (13/15 A in genome downstream of last aligned base) | 662/686 (96 %) | 7 diff (99.0 %id) |
CK126055 | embryonic stem cell, Embryonic stem cell, pooled H7 ES cell line,passage 22 | .e | 79 to 792 | 32 to 744 | Q193S | AAA | Possibly primed on the genome, locally A rich (13/15 A in genome downstream of last aligned base) | 713/744 (95 %) | 9 diff (98.8 %id) |
TI_57217262 | .e | 141 to 789 | 34 to 682 | N186I F187S E188N F189X P190Q ... | AAA | Possibly primed on the genome, locally A rich (13/15 A in genome downstream of last aligned base) | 649/682 (95 %) | 4 diff (99.5 %id) | |
TI_57151720 | .e | 148 to 792 | 27 to 672 | exact | AAA | Possibly primed on the genome, locally A rich (13/15 A in genome downstream of last aligned base) | 646/672 (96 %) | 7 diff (99.0 %id) | |
TI_57177736 | .e | 152 to 793 | 46 to 687 | E52D V53S L83X I139X L158X ... | 642/756 (84 %) | 11 diff (98.6 %id) | |||
TI_57179073 | .e | 151 to 793 | 14 to 656 | exact | 643/780 (82 %) | 7 diff (99.2 %id) | |||
TI_57232723 | .e | 160 to 793 | 31 to 663 | F2V L194W | 633/892 (70 %) | 8 diff (99.2 %id) | |||
TI_57236571 | .e | 152 to 792 | 39 to 677 | L40S R41G E42S L43* | AAA | Possibly primed on the genome, locally A rich (13/15 A in genome downstream of last aligned base) | 639/677 (94 %) | 8 diff (98.9 %id) | |
TI_57171602 | .e | 139 to 793 | 69 to 722 | exact | 654/1032 (63 %) | 7 diff (99.4 %id) | |||
TI_57173080 | .e | 143 to 784 | 29 to 684 | F63L V64F V66F P67L Q68N ... | 626/684 (91 %) | 11 diff (98.4 %id) | |||
TI_57175829 | .e | 139 to 793 | 62 to 717 | L83V T105S R106S S108K R109P ... | 656/871 (75 %) | 11 diff (98.8 %id) | |||
TI_44185077 | .m | 12 to 823 | 28 to 839 | exact | 812/839 (96 %) | 8 diff (99.1 %id) | |||
TI_57243133 | .e | 143 to 792 | 33 to 682 | K155T | AAA | Possibly primed on the genome, locally A rich (13/15 A in genome downstream of last aligned base) | 650/682 (95 %) | 1 diff (99.9 %id) | |
TI_45210580 | .e | 128 to 793 | 128 to 793 | exact | 666/806 (82 %) | 8 diff (99.1 %id) | |||
TI_45212937 | .e | 116 to 791 | 120 to 794 | Q25* | 675/891 (75 %) | 9 diff (99.0 %id) | |||
TI_44343220 | .e | 117 to 792 | 131 to 811 | K169Q V170D E171* | 679/1010 (67 %) | 17 diff (98.4 %id) | |||
TI_44345451 | .e | 134 to 792 | 92 to 750 | exact | AAA | Possibly primed on the genome, locally A rich (13/15 A in genome downstream of last aligned base) | 659/750 (87 %) | 6 diff (99.2 %id) | |
TI_44345465 | .e | 117 to 793 | 85 to 760 | V170I K179E L180A T181H K183Q | 676/938 (72 %) | 15 diff (98.5 %id) | |||
TI_57186945 | .e | 345 to 789 | 54 to 498 | AAA | Possibly primed on the genome, locally A rich (13/15 A in genome downstream of last aligned base) | 445/445 (100 %) | 0 diff (100 %id) | ||
TI_57189144 | .e | 151 to 793 | 17 to 660 | N186Q E188* | 644/707 (91 %) | 8 diff (98.9 %id) | |||
TI_57189463 | .e | 300 to 792 | 48 to 540 | AAA | Possibly primed on the genome, locally A rich (13/15 A in genome downstream of last aligned base) | 493/493 (100 %) | 0 diff (100 %id) | ||
TI_57189871 | .e | 148 to 789 | 88 to 728 | L83X I139M V140W G141A K142R ... | AAA | Possibly primed on the genome, locally A rich (13/15 A in genome downstream of last aligned base) | 641/641 (100 %) | 4 diff (99.4 %id) | |
TI_57189998 | .e | 346 to 792 | 54 to 500 | AAA | Possibly primed on the genome, locally A rich (13/15 A in genome downstream of last aligned base) | 447/447 (100 %) | 1 diff (99.8 %id) | ||
TI_57191329 | .e | 162 to 792 | 52 to 683 | L158F D159G K160Q A161S Q162T ... | AAA | Possibly primed on the genome, locally A rich (13/15 A in genome downstream of last aligned base) | 632/632 (100 %) | 1 diff (99.9 %id) | |
TI_57191412 | .e | 143 to 792 | 53 to 702 | exact | AAA | Possibly primed on the genome, locally A rich (13/15 A in genome downstream of last aligned base) | 650/650 (100 %) | 0 diff (100 %id) | |
TI_57191985. matches multiple genes | .e | 149 to 724 | 30 to 618 | also hits gene RPS7P1 | 589/834 (70 %) | 27 diff (96.8 %id) | |||
TI_57192135 | .e | 421 to 793 | 50 to 422 | AAA | 373/782 (47 %) | 1 diff (99.9 %id) | |||
TI_57230717 | .d | 41 to 645 | 89 to 697 | E84D K85E K86T F87S G89V ... | 609/803 (75 %) | 13 diff (98.4 %id) | |||
TI_59386099. matches multiple genes | .e | 133 to 790 | 135 to 792 | T46M | also hits gene RPS7P1 | 658/853 (77 %) | 2 diff (99.8 %id) | ||
TI_59383927 | .e | 144 to 793 | 99 to 748 | exact | 650/783 (83 %) | 1 diff (99.9 %id) | |||
TI_59385104 | .e | 147 to 724 | 104 to 688 | 585/799 (73 %) | 11 diff (98.7 %id) | ||||
TI_59385404 | .e | 106 to 789 | 103 to 786 | L194I | AAA | Possibly primed on the genome, locally A rich (13/15 A in genome downstream of last aligned base) | 684/684 (100 %) | 3 diff (99.6 %id) | |
TI_59385619 | .e | 148 to 721 | 104 to 682 | 579/821 (70 %) | 8 diff (99.1 %id) | ||||
TI_59391977 | .e | 130 to 793 | 88 to 751 | exact | 664/830 (80 %) | 2 diff (99.8 %id) | |||
TI_59392044 | .e | 141 to 762 | 91 to 722 | K7T D35G L36P K37S A38R ... | 632/737 (85 %) | 22 diff (97.1 %id) | |||
TI_59392332 | .e | 179 to 515 | 98 to 433 | AAA | Internal priming: the 3' end of the oligo dT primed clone lies in the CDS | 336/509 (66 %) | 4 diff (99.3 %id) | ||
TI_59392354 | .e | 156 to 793 | 96 to 733 | L194S | 638/736 (86 %) | 4 diff (99.5 %id) | |||
TI_59392482 | .e | 445 to 789 | 96 to 440 | AAA | Possibly primed on the genome, locally A rich (13/15 A in genome downstream of last aligned base) | 345/345 (100 %) | 0 diff (100 %id) | ||
TI_59392721 | .e | 142 to 792 | 89 to 740 | V176C Y177L K178* | AAA | Possibly primed on the genome, locally A rich (13/15 A in genome downstream of last aligned base) | 652/652 (100 %) | 2 diff (99.7 %id) | |
TI_59392805 | .e | 152 to 793 | 97 to 741 | K155Q V156G H157S L158F D159G ... | 645/906 (71 %) | 11 diff (98.8 %id) | |||
N85270 | .e | 163 to 312 | 1 to 148 | 148/148 (100 %) | 13 diff (91.3 %id) | ||||
M77233 | .e | 177 to 776 | 1 to 600 | 600/600 (100 %) | 1 diff (99.9 %id) | ||||
BY994077 | .e | 245 to 792 | 26 to 573 | AAA | Possibly primed on the genome, locally A rich (13/15 A in genome downstream of last aligned base) | 548/573 (95 %) | 6 diff (99.0 %id) | ||
BY994574 | .e | 152 to 784 | 25 to 657 | exact | 633/657 (96 %) | 6 diff (99.1 %id) | |||
BY995033 | .e | 152 to 792 | 43 to 683 | exact | AAA | Possibly primed on the genome, locally A rich (13/15 A in genome downstream of last aligned base) | 641/683 (93 %) | 6 diff (99.2 %id) | |
DA649761 | .k | 419 to 970 | 2 to 553 | capped | 552/552 (100 %) | 0 diff (100 %id) | |||
DB321661 | .k | 2446 to 3001 | 556 to 1 | 556/556 (100 %) | 1 diff (99.9 %id) | ||||
DA656445 | .m | 1 to 575 | 2 to 576 | tiling clone, capped | 575/576 (99 %) | 3 diff (99.5 %id) | |||
DV461736 | cochlea, ear | .e | 198 to 410 | 213 to 1 | Submitted on the opposite strand | 213/213 (100 %) | 1 diff (99.6 %id) | ||
DV460226 | cochlea, ear | .e | 242 to 410 | 169 to 1 | Submitted on the opposite strand | 169/169 (100 %) | 2 diff (98.9 %id) | ||
DV460474 | cochlea, ear | .e | 270 to 410 | 1 to 141 | 141/141 (100 %) | 0 diff (100 %id) | |||
DV461358 | cochlea, ear | .e | 270 to 410 | 1 to 141 | 141/141 (100 %) | 0 diff (100 %id) | |||
DV460848 | cochlea, ear | .e | 192 to 405 | 1 to 214 | 214/219 (97 %) | 3 diff (98.7 %id) | |||
NM_001011.3 | .e | 66 to 792 | 1 to 727 | exact | RefSeq, AAA | Possibly primed on the genome, locally A rich (13/15 A in genome downstream of last aligned base) | 727/727 (100 %) | 0 diff (100 %id) | |
AV751200 | Pituitary | .e | 230 to 373 | 1 to 149 | 149/160 (93 %) | 13 diff (91.9 %id) | |||
DB365653. matches multiple genes | .e | 214 to 789 | 573 to 1 | also hits gene RPS7P10 | 575/574 (100 %) | 9 diff (98.5 %id) | |||
DB366597. matches multiple genes | .e | 240 to 792 | 548 to 1 | also hits gene RPS7P11 | 548/560 (97 %) | 16 diff (97.2 %id) | |||
DA758549 | .k | 1 to 553 | 2 to 556 | A6S K7Q I8D V9R K10E ... | tiling clone, capped | 555/555 (100 %) | 2 diff (99.7 %id) | ||
DA783801 | brain | .i | 2645 to 3109 | 2 to 468 | capped | 467/467 (100 %) | 3 diff (99.4 %id) | ||
CV574227 | cornea, eye | .e | 140 to 772 | 1 to 633 | exact | 633/633 (100 %) | 0 diff (100 %id) | ||
DA828044 | placenta | .e | 129 to 791 | 2 to 665 | R118X D159X E191K | fully sequenced, capped | 664/664 (100 %) | 3 diff (99.6 %id) | |
DB372454 | placenta | .e | 497 to 792 | 295 to 1 | fully sequenced, | 295/295 (100 %) | 1 diff (99.7 %id) | ||
DA882403 | .i | 2357 to 2887 | 2 to 533 | capped | 532/532 (100 %) | 4 diff (99.3 %id) | |||
CR977085 | T-Lymphocytes | .f | 341 to 1045 | 1 to 705 | tiling clone, | 705/705 (100 %) | 0 diff (100 %id) | ||
CT002471 | T-Lymphocytes | .f | 314 to 1000 | 1 to 687 | 687/689 (99 %) | 1 diff (99.9 %id) | |||
BM746174 | stomach | .e | 160 to 366 | 1 to 207 | 207/207 (100 %) | 0 diff (100 %id) | |||
F35482 | pectoral muscle (after mastectomy) | .j | 49 to 302 | 1 to 254 | 254/254 (100 %) | 4 diff (98.5 %id) | |||
BM756952 | Ascites, stomach | .e | 174 to 378 | 1 to 205 | 205/205 (100 %) | 1 diff (99.6 %id) | |||
BM828407 | stomach | .e | 97 to 767 | 1 to 671 | exact | 671/671 (100 %) | 0 diff (100 %id) | ||
BM835860 | stomach | .b | 1 to 430 | 1 to 430 | tiling clone, | 430/430 (100 %) | 1 diff (99.8 %id) | ||
BM791268 | stomach | .e | 128 to 791 | 1 to 664 | exact | 664/664 (100 %) | 0 diff (100 %id) | ||
BM798231 | Ascites, stomach | .d | 1 to 184 | 1 to 185 | 185/185 (100 %) | 3 diff (98.4 %id) | |||
TI_1948145457. matches multiple genes | .e | 171 to 644 | 133 to 606 | also hits gene RPS7P11 | 474/1279 (37 %) | 10 diff (99.3 %id) | |||
DA908799 | .g | 1 to 556 | 2 to 558 | tiling clone, capped | 557/557 (100 %) | 1 diff (99.9 %id) | |||
DA937142 | Spleen | .l | 1 to 547 | 2 to 548 | D35G | tiling clone, capped | 547/547 (100 %) | 1 diff (99.9 %id) | |
DB102604 | thymus | .e | 129 to 682 | 2 to 555 | capped | 554/554 (100 %) | 0 diff (100 %id) | ||
DB107303 | thymus | .d | 18 to 585 | 2 to 569 | capped | 568/568 (100 %) | 0 diff (100 %id) | ||
DB135481 | thymus | .k | 3 to 558 | 2 to 557 | exact | capped | 556/556 (100 %) | 0 diff (100 %id) | |
DB139612 | thymus | .k | 3 to 535 | 2 to 535 | A47G A48S K49* | capped | 534/534 (100 %) | 1 diff (99.9 %id) | |
DB155352 | thymus | .k | 3 to 585 | 2 to 584 | exact | capped | 583/583 (100 %) | 1 diff (99.9 %id) | |
TI_149271961 | .e | 291 to 789 | 594 to 96 | AAA | Possibly primed on the genome, locally A rich (13/15 A in genome downstream of last aligned base) | 499/980 (50 %) | 3 diff (99.7 %id) | ||
TI_149273298 | .e | 128 to 775 | 56 to 703 | K10N K160R P190X | Submitted on the opposite strand | 648/924 (70 %) | 9 diff (99.1 %id) | ||
TI_149273773 | .e | 128 to 793 | 53 to 717 | P190A | Submitted on the opposite strand | 665/942 (70 %) | 10 diff (99.0 %id) | ||
TI_149274865 | .c | 34 to 411 | 463 to 86 | AAA | 378/1001 (37 %) | 0 diff (100 %id) | |||
TI_149275478 | .e | 176 to 792 | 704 to 88 | AAA | Possibly primed on the genome, locally A rich (13/15 A in genome downstream of last aligned base) | 617/1015 (60 %) | 0 diff (100 %id) | ||
TI_149286814 | .e | 152 to 792 | 717 to 78 | K70N S71L F72S Q73R I75S ... | AAA | Possibly primed on the genome, locally A rich (13/15 A in genome downstream of last aligned base) | 640/1076 (59 %) | 1 diff (100.0 %id) | |
TI_149289678 | .e | 148 to 792 | 88 to 734 | L158F D159G K160Q A161S Q162T ... | AAA | Submitted on the opposite strand | 647/647 (100 %) | 5 diff (99.3 %id) | |
TI_149313094 | .e | 141 to 792 | 739 to 88 | exact | AAA | Possibly primed on the genome, locally A rich (13/15 A in genome downstream of last aligned base) | 652/980 (66 %) | 0 diff (100 %id) | |
TI_154015939 | .e | 152 to 792 | 726 to 86 | exact | AAA | Possibly primed on the genome, locally A rich (13/15 A in genome downstream of last aligned base) | 641/989 (64 %) | 0 diff (100 %id) | |
TI_154019208 | .e | 436 to 792 | 449 to 92 | AAA | Possibly primed on the genome, locally A rich (13/15 A in genome downstream of last aligned base) | 358/726 (49 %) | 1 diff (99.9 %id) | ||
TI_154047908 | .e | 98 to 792 | 789 to 97 | F72P Q73E K74N I75P Q76S ... | AAA | Possibly primed on the genome, locally A rich (13/15 A in genome downstream of last aligned base) | 693/945 (73 %) | 8 diff (99.2 %id) | |
TI_154050883 | .e | 154 to 792 | 731 to 92 | exact | AAA | Possibly primed on the genome, locally A rich (13/15 A in genome downstream of last aligned base) | 640/962 (66 %) | 5 diff (99.5 %id) | |
TI_154124454 | .f | 767 to 1424 | 724 to 69 | tiling clone, AAA | Possibly primed on the genome, locally A rich (13/15 A in genome downstream of last aligned base) | 656/926 (70 %) | 6 diff (99.4 %id) | ||
TI_154133424 | .e | 151 to 792 | 749 to 110 | S3X A6X I8S V9* | AAA | Possibly primed on the genome, locally A rich (13/15 A in genome downstream of last aligned base) | 640/831 (77 %) | 6 diff (99.3 %id) | |
TI_154141267 | .e | 186 to 674 | 89 to 577 | 489/499 (97 %) | 9 diff (98.2 %id) | ||||
TI_154141347 | .e | 190 to 690 | 85 to 585 | 501/501 (100 %) | 0 diff (100 %id) | ||||
TI_154141615 | .e | 182 to 764 | 80 to 657 | 578/757 (76 %) | 18 diff (97.7 %id) | ||||
TI_154141668 | .e | 182 to 792 | 81 to 692 | 612/770 (79 %) | 4 diff (99.5 %id) | ||||
TI_154141816 | .e | 144 to 786 | 81 to 733 | V134D I139F V140C K142E R143E ... | 653/710 (91 %) | 29 diff (96.0 %id) | |||
TI_154142499 | .e | 190 to 792 | 92 to 692 | AAA | Possibly primed on the genome, locally A rich (13/15 A in genome downstream of last aligned base) | 601/601 (100 %) | 16 diff (97.4 %id) | ||
TI_154146735 | .e | 162 to 604 | 84 to 526 | 443/443 (100 %) | 6 diff (98.7 %id) | ||||
TI_154182351. matches multiple genes | .e | 126 to 793 | 104 to 776 | F87S S88V K90S H91M V92S ... | tiling clone, AAA | Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base), also hits gene RPS7P1 | 673/854 (78 %) | 27 diff (96.9 %id) | |
TI_154183565 | .e | 93 to 791 | 91 to 787 | K86N F87S S88V K90S H91M ... | tiling clone, AAA | Possibly primed on the genome, locally A rich (13/15 A in genome downstream of last aligned base) | 697/721 (96 %) | 11 diff (98.5 %id) | |
TI_154184946 | .e | 253 to 792 | 109 to 648 | AAA | Possibly primed on the genome, locally A rich (13/15 A in genome downstream of last aligned base) | 540/570 (94 %) | 8 diff (98.6 %id) | ||
TI_154190585 | .e | 387 to 800 | 179 to 592 | 414/981 (42 %) | 14 diff (98.6 %id) | ||||
TI_154191718 | .e | 364 to 792 | 51 to 478 | AAA | Possibly primed on the genome, locally A rich (13/15 A in genome downstream of last aligned base) | 428/428 (100 %) | 1 diff (99.8 %id) | ||
TI_154192621 | .e | 191 to 790 | 51 to 650 | 600/966 (62 %) | 9 diff (99.1 %id) | ||||
DB213765 | trachea | .i | 1853 to 2408 | 2 to 558 | capped | 557/557 (100 %) | 1 diff (99.9 %id) | ||
DB232618 | trachea | .l | 1 to 553 | 2 to 554 | F94L | tiling clone, capped | 553/553 (100 %) | 1 diff (99.9 %id) | |
BQ028517 | placenta, Placenta Choriocarcinoma | .e | 138 to 792 | 673 to 19 | exact | AAA | Possibly primed on the genome, locally A rich (13/15 A in genome downstream of last aligned base) | 655/655 (100 %) | 0 diff (100 %id) |
CF541148 | lung | .d | 41 to 672 | 650 to 19 | exact | AAA | Possibly primed on the genome, locally A rich (13/15 A in genome downstream of last aligned base) | 632/632 (100 %) | 0 diff (100 %id) |
BM662445 | eye, RPE and Choroid | .e | 291 to 789 | 514 to 16 | AAA | Possibly primed on the genome, locally A rich (13/15 A in genome downstream of last aligned base) | 499/499 (100 %) | 0 diff (100 %id) | |
BM708102. matches multiple genes | eye, RPE and Choroid | .e | 143 to 582 | 1 to 440 | also hits gene RPS7P11 | 440/440 (100 %) | 0 diff (100 %id) | ||
BM668726 | eye, Retina Foveal and Macular | .e | 497 to 792 | 314 to 19 | fully sequenced, AAA | Possibly primed on the genome, locally A rich (13/15 A in genome downstream of last aligned base) | 296/296 (100 %) | 0 diff (100 %id) | |
BM693449 | eye, Retina Foveal and Macular | .e | 197 to 558 | 1 to 362 | fully sequenced, | Possibly primed on the genome, locally A rich (13/15 A in genome downstream of last aligned base) | 362/362 (100 %) | 0 diff (100 %id) | |
BM696533. matches multiple genes | eye, lens | .e | 178 to 735 | 1 to 563 | also hits gene RPS7P3 | 561/563 (99 %) | 4 diff (99.3 %id) | ||
BM700073 | eye, lens | .e | 266 to 789 | 1 to 524 | fully sequenced, AAA | Possibly primed on the genome, locally A rich (13/15 A in genome downstream of last aligned base) | 524/524 (100 %) | 0 diff (100 %id) | |
BU737874 | eye, lens | .e | 497 to 789 | 309 to 17 | fully sequenced, AAA | Possibly primed on the genome, locally A rich (13/15 A in genome downstream of last aligned base) | 293/293 (100 %) | 0 diff (100 %id) | |
CA437118 | lung, Metastatic Chondrosarcoma | .e | 152 to 792 | 659 to 19 | exact | AAA | Possibly primed on the genome, locally A rich (13/15 A in genome downstream of last aligned base) | 641/659 (97 %) | 0 diff (100 %id) |
BQ771964 | Chondrosarcoma Grade II, Left Pelvis | .e | 155 to 792 | 656 to 19 | exact | AAA | Possibly primed on the genome, locally A rich (13/15 A in genome downstream of last aligned base) | 638/638 (100 %) | 1 diff (99.9 %id) |
CA430606 | Cell Line, Chondrosarcoma | .e | 138 to 792 | 673 to 19 | exact | AAA | Possibly primed on the genome, locally A rich (13/15 A in genome downstream of last aligned base) | 655/655 (100 %) | 0 diff (100 %id) |
BU633488 | cell lines, Chondrosarcoma | .e | 152 to 789 | 656 to 19 | exact | AAA | Possibly primed on the genome, locally A rich (13/15 A in genome downstream of last aligned base) | 638/645 (98 %) | 0 diff (100 %id) |
CA306668 | Alveolar Macrophage, lung | .e | 147 to 792 | 664 to 19 | exact | AAA | Possibly primed on the genome, locally A rich (13/15 A in genome downstream of last aligned base) | 646/655 (98 %) | 0 diff (100 %id) |
CA309704 | Alveolar Macrophage, lung | .e | 161 to 792 | 650 to 19 | exact | AAA | Possibly primed on the genome, locally A rich (13/15 A in genome downstream of last aligned base) | 632/632 (100 %) | 1 diff (99.9 %id) |
DB252727 | uterus | .k | 3 to 582 | 2 to 581 | exact | tiling clone, capped | 580/580 (100 %) | 0 diff (100 %id) | |
DB254053 | uterus | .l | 1 to 494 | 2 to 497 | S34V D35G L36P K37Q A38G ... | capped | 496/496 (100 %) | 2 diff (99.6 %id) | |
X74803 | Kidney | .e | 565 to 738 | 10 to 180 | 171/180 (95 %) | 6 diff (96.7 %id) | |||
AU077323 | .e | 128 to 221 | 1 to 94 | 94/94 (100 %) | 0 diff (100 %id) | ||||
BP381026 | .e | 129 to 716 | 1 to 588 | 588/588 (100 %) | 4 diff (99.4 %id) | ||||
BQ683416 | melanotic melanoma, cell line, skin | .d | 41 to 669 | 1 to 629 | exact | AAA | Possibly primed on the genome, locally A rich (13/15 A in genome downstream of last aligned base) | 629/629 (100 %) | 0 diff (100 %id) |
BQ683416 | melanotic melanoma, cell line, skin | .d | 41 to 669 | 1 to 629 | exact | AAA | Possibly primed on the genome, locally A rich (13/15 A in genome downstream of last aligned base) | 629/629 (100 %) | 0 diff (100 %id) |
BU839342 | IMAGE:6263245 | RPS7.eAug10 | 786 | 637 | IMAGE:6263245 | 637 | 1 | ||
BU839342 | IMAGE:6263245 | RPS7.eAug10 | 786 | 637 | IMAGE:6263245 | 637 | 1 | ||
BQ683072 | IMAGE:6264102 | RPS7.eAug10 | 788 | 639 | IMAGE:6264102 | 639 | 1 | ||
BQ683072 | IMAGE:6264102 | RPS7.eAug10 | 788 | 639 | IMAGE:6264102 | 639 | 1 | ||
BQ646704 | IMAGE:6268714 | RPS7.eAug10 | 792 | 644 | IMAGE:6268714 | Anomalous_clone | 644 | 0 | |
BQ646704 | IMAGE:6268714 | RPS7.eAug10 | 792 | 644 | IMAGE:6268714 | Anomalous_clone | 644 | 0 | |
BQ645396 | IMAGE:6269330 | RPS7.dAug10 | 672 | 632 | IMAGE:6269330 | Anomalous_clone | 632 | 4 | |
BQ645396 | IMAGE:6269330 | RPS7.dAug10 | 672 | 632 | IMAGE:6269330 | Anomalous_clone | 632 | 4 | |
BQ673214 | IMAGE:6272491 | RPS7.eAug10 | 792 | 651 | IMAGE:6272491 | Anomalous_clone | 651 | 0 | |
BQ673214 | IMAGE:6272491 | RPS7.eAug10 | 792 | 651 | IMAGE:6272491 | Anomalous_clone | 651 | 0 | |
BQ674366 | IMAGE:6277392 | RPS7.eAug10 | 792 | 651 | IMAGE:6277392 | Anomalous_clone | 651 | 0 | |
BQ674366 | IMAGE:6277392 | RPS7.eAug10 | 792 | 651 | IMAGE:6277392 | Anomalous_clone | 651 | 0 | |
BQ654312 | IMAGE:6293996 | RPS7.eAug10 | 792 | 644 | IMAGE:6293996 | Anomalous_clone | 644 | 0 | |
BQ654312 | IMAGE:6293996 | RPS7.eAug10 | 792 | 644 | IMAGE:6293996 | Anomalous_clone | 644 | 0 | |
BQ901091 | IMAGE:6300001 | RPS7.eAug10 | 792 | 651 | IMAGE:6300001 | Anomalous_clone | 651 | 0 | |
BQ901091 | IMAGE:6300001 | RPS7.eAug10 | 792 | 651 | IMAGE:6300001 | Anomalous_clone | 651 | 0 | |
BQ898602 | IMAGE:6304198 | RPS7.eAug10 | 792 | 644 | IMAGE:6304198 | Anomalous_clone | 644 | 0 | |
BQ898602 | IMAGE:6304198 | RPS7.eAug10 | 792 | 644 | IMAGE:6304198 | Anomalous_clone | 644 | 0 | |
BU501485 | IMAGE:6341290 | RPS7.eAug10 | 792 | 693 | IMAGE:6341290 | 693 | 2 | ||
BU501485 | IMAGE:6341290 | RPS7.eAug10 | 792 | 693 | IMAGE:6341290 | 693 | 2 | ||
BQ935881 | IMAGE:6371511 | RPS7.eAug10 | 792 | 661 | IMAGE:6371511 | Anomalous_clone | 661 | 0 | |
BQ935881 | IMAGE:6371511 | RPS7.eAug10 | 792 | 661 | IMAGE:6371511 | Anomalous_clone | 661 | 0 | |
BQ956492 | IMAGE:6421012 | RPS7.eAug10 | 792 | 641 | IMAGE:6421012 | Anomalous_clone | 641 | 0 | |
BQ956492 | IMAGE:6421012 | RPS7.eAug10 | 792 | 641 | IMAGE:6421012 | Anomalous_clone | 641 | 0 | |
BQ955188 | IMAGE:6422621 | RPS7.eAug10 | 789 | 628 | IMAGE:6422621 | Anomalous_clone | 628 | 0 | |
BQ955188 | IMAGE:6422621 | RPS7.eAug10 | 789 | 628 | IMAGE:6422621 | Anomalous_clone | 628 | 0 | |
BQ943066 | IMAGE:6424457 | RPS7.eAug10 | 792 | 644 | IMAGE:6424457 | Anomalous_clone | 644 | 0 | |
BQ943066 | IMAGE:6424457 | RPS7.eAug10 | 792 | 644 | IMAGE:6424457 | Anomalous_clone | 644 | 0 | |
BQ932635 | IMAGE:6459324 | RPS7.eAug10 | 792 | 631 | IMAGE:6459324 | Anomalous_clone | 631 | 0 | |
BQ932635 | IMAGE:6459324 | RPS7.eAug10 | 792 | 631 | IMAGE:6459324 | Anomalous_clone | 631 | 0 | |
BQ929365 | IMAGE:6460679 | RPS7.eAug10 | 792 | 644 | IMAGE:6460679 | Anomalous_clone | 644 | 0 | |
BQ929365 | IMAGE:6460679 | RPS7.eAug10 | 792 | 644 | IMAGE:6460679 | Anomalous_clone | 644 | 0 | |
BU506749 | IMAGE:6498762 | RPS7.bAug10 | 651 | 533 | IMAGE:6498762 | 533 | 9 | ||
BU507039 | IMAGE:6500923 | RPS7.eAug10 | 792 | 714 | IMAGE:6500923 | 714 | 1 | ||
BU507039 | IMAGE:6500923 | RPS7.eAug10 | 792 | 714 | IMAGE:6500923 | 714 | 1 | ||
BU521515 | IMAGE:6527381 | RPS7.eAug10 | 792 | 657 | IMAGE:6527381 | Anomalous_clone | 646 | 0 | |
BU521515 | IMAGE:6527381 | RPS7.eAug10 | 792 | 657 | IMAGE:6527381 | Anomalous_clone | 646 | 0 | |
CA941850 | IMAGE:6548217 | RPS7.eAug10 | 793 | 5 | IMAGE:6548217 | 607 | 0 | ||
CA941850 | IMAGE:6548217 | RPS7.eAug10 | 793 | 5 | IMAGE:6548217 | 607 | 0 | ||
CA941805 | IMAGE:6548243 | RPS7.eAug10 | 792 | 1 | IMAGE:6548243 | 296 | 0 | ||
CA941805 | IMAGE:6548243 | RPS7.eAug10 | 792 | 1 | IMAGE:6548243 | 296 | 0 | ||
CA941981 | IMAGE:6548243 | RPS7.eAug10 | 774 | 535 | IMAGE:6548243 | 535 | 0 | ||
CA941981 | IMAGE:6548243 | RPS7.eAug10 | 774 | 535 | IMAGE:6548243 | 535 | 0 | ||
BU533085 | IMAGE:6559209 | RPS7.eAug10 | 793 | 668 | IMAGE:6559209 | 668 | 3 | ||
BU534073 | IMAGE:6560792 | RPS7.bAug10 | 575 | 566 | IMAGE:6560792 | 566 | 19 | ||
BU553728 | IMAGE:6580861 | RPS7.eAug10 | 793 | 642 | IMAGE:6580861 | Anomalous_clone | 642 | 1 | |
BU553728 | IMAGE:6580861 | RPS7.eAug10 | 793 | 642 | IMAGE:6580861 | Anomalous_clone | 642 | 1 | |
BU558145 | IMAGE:6586412 | RPS7.eAug10 | 789 | 654 | IMAGE:6586412 | Anomalous_clone | 654 | 0 | |
BU558145 | IMAGE:6586412 | RPS7.eAug10 | 789 | 654 | IMAGE:6586412 | Anomalous_clone | 654 | 0 | |
BU849995 | IMAGE:6598745 | RPS7.eAug10 | 791 | 680 | IMAGE:6598745 | 680 | 1 | ||
BU849995 | IMAGE:6598745 | RPS7.eAug10 | 791 | 680 | IMAGE:6598745 | 680 | 1 | ||
CA942820 | IMAGE:6607181 | RPS7.eAug10 | 748 | 627 | IMAGE:6607181 | 618 | 1 | ||
CA942820 | IMAGE:6607181 | RPS7.eAug10 | 748 | 627 | IMAGE:6607181 | 618 | 1 | ||
CA942868 | IMAGE:6607477 | RPS7.eAug10 | 753 | 599 | IMAGE:6607477 | 599 | 2 | ||
CA942868 | IMAGE:6607477 | RPS7.eAug10 | 753 | 599 | IMAGE:6607477 | 599 | 2 | ||
CA868564 | IMAGE:6608880 | RPS7.eAug10 | 793 | 4 | IMAGE:6608880 | 583 | 0 | ||
CA868564 | IMAGE:6608880 | RPS7.eAug10 | 793 | 4 | IMAGE:6608880 | 583 | 0 | ||
BU934981 | IMAGE:6701999 | RPS7.iAug10 | 3291 | 795 | IMAGE:6701999 | 795 | 8 | ||
BU941853 | IMAGE:6714241 | RPS7.eAug10 | 678 | 647 | IMAGE:6714241 | 647 | 5 | ||
CX784239 | IMAGE:7478613 | RPS7.fAug10 | 972 | 696 | IMAGE:7478613 | 696 | 0 | ||
CV801755 | IMAGE:7505263 | RPS7.eAug10 | 793 | 646 | IMAGE:7505263 | 646 | 5 | ||
CV801755 | IMAGE:7505263 | RPS7.eAug10 | 793 | 646 | IMAGE:7505263 | 646 | 5 | ||
CB594656 | IMAGE:30255426 | RPS7.eAug10 | 792 | 712 | IMAGE:30255426 | Anomalous_clone | 712 | 0 | |
CD109217 | IMAGE:30365981 | RPS7.eAug10 | 792 | 643 | IMAGE:30365981 | Anomalous_clone | 643 | 0 | |
CD109217 | IMAGE:30365981 | RPS7.eAug10 | 792 | 643 | IMAGE:30365981 | Anomalous_clone | 643 | 0 | |
CD641774 | IMAGE:30418223 | RPS7.bAug10 | 747 | 660 | IMAGE:30418223 | 660 | 6 | ||
CK126125 | IMAGE:30709672 | RPS7.eAug10 | 792 | 686 | IMAGE:30709672 | Anomalous_clone | 662 | 7 | |
CK126125 | IMAGE:30709672 | RPS7.eAug10 | 792 | 686 | IMAGE:30709672 | Anomalous_clone | 662 | 7 | |
CK126055 | IMAGE:30709968 | RPS7.eAug10 | 792 | 744 | IMAGE:30709968 | Anomalous_clone | 713 | 9 | |
CK126055 | IMAGE:30709968 | RPS7.eAug10 | 792 | 744 | IMAGE:30709968 | Anomalous_clone | 713 | 9 | |
TI_57217262 | INCYTE_603025186 | RPS7.eAug10 | 789 | 682 | INCYTE_603025186 | Anomalous_clone | 649 | 4 | |
TI_57151720 | INCYTE_603049679 | RPS7.eAug10 | 792 | 672 | INCYTE_603049679 | Anomalous_clone | 646 | 7 | |
TI_57177736 | INCYTE_603052676 | RPS7.eAug10 | 793 | 687 | INCYTE_603052676 | 642 | 11 | ||
TI_57179073 | INCYTE_603054568 | RPS7.eAug10 | 793 | 656 | INCYTE_603054568 | 643 | 7 | ||
TI_57232723 | INCYTE_603063882 | RPS7.eAug10 | 793 | 663 | INCYTE_603063882 | 633 | 8 | ||
TI_57236571 | INCYTE_603068945 | RPS7.eAug10 | 792 | 677 | INCYTE_603068945 | Anomalous_clone | 639 | 8 | |
TI_57171602 | INCYTE_603073687 | RPS7.eAug10 | 793 | 722 | INCYTE_603073687 | 654 | 7 | ||
TI_57173080 | INCYTE_603075575 | RPS7.eAug10 | 784 | 684 | INCYTE_603075575 | 626 | 11 | ||
TI_57175829 | INCYTE_603079190 | RPS7.eAug10 | 793 | 717 | INCYTE_603079190 | 656 | 11 | ||
TI_44185077 | INCYTE_603175410 | RPS7.mAug10 | 823 | 839 | INCYTE_603175410 | 812 | 8 | ||
TI_57243133 | INCYTE_603182873 | RPS7.eAug10 | 792 | 682 | INCYTE_603182873 | Anomalous_clone | 650 | 1 | |
TI_45210580 | INCYTE_603244973 | RPS7.eAug10 | 793 | 793 | INCYTE_603244973 | 666 | 8 | ||
TI_45212937 | INCYTE_603247672 | RPS7.eAug10 | 791 | 794 | INCYTE_603247672 | 675 | 9 | ||
TI_44343220 | INCYTE_603291992 | RPS7.eAug10 | 792 | 811 | INCYTE_603291992 | 679 | 17 | ||
TI_44345451 | INCYTE_603294686 | RPS7.eAug10 | 792 | 750 | INCYTE_603294686 | Anomalous_clone | 659 | 6 | |
TI_44345465 | INCYTE_603294705 | RPS7.eAug10 | 793 | 760 | INCYTE_603294705 | 676 | 15 | ||
TI_57186945 | INCYTE_603383893 | RPS7.eAug10 | 789 | 498 | INCYTE_603383893 | Anomalous_clone | 445 | 0 | |
TI_57189144 | INCYTE_603386412 | RPS7.eAug10 | 793 | 660 | INCYTE_603386412 | 644 | 8 | ||
TI_57189463 | INCYTE_603386771 | RPS7.eAug10 | 792 | 540 | INCYTE_603386771 | Anomalous_clone | 493 | 0 | |
TI_57189871 | INCYTE_603387224 | RPS7.eAug10 | 789 | 728 | INCYTE_603387224 | Anomalous_clone | 641 | 4 | |
TI_57189998 | INCYTE_603387362 | RPS7.eAug10 | 792 | 500 | INCYTE_603387362 | Anomalous_clone | 447 | 1 | |
TI_57191329 | INCYTE_603388848 | RPS7.eAug10 | 792 | 683 | INCYTE_603388848 | Anomalous_clone | 632 | 1 | |
TI_57191412 | INCYTE_603388943 | RPS7.eAug10 | 792 | 702 | INCYTE_603388943 | Anomalous_clone | 650 | 0 | |
TI_57191985 | INCYTE_603389751 | RPS7.eAug10 | 724 | 618 | INCYTE_603389751 | 589 | 27 | ||
TI_57192135 | INCYTE_603389961 | RPS7.eAug10 | 793 | 422 | INCYTE_603389961 | 373 | 1 | ||
TI_57230717 | INCYTE_603395458 | RPS7.dAug10 | 645 | 697 | INCYTE_603395458 | 609 | 13 | ||
TI_59386099 | INCYTE_603613941 | RPS7.eAug10 | 790 | 792 | INCYTE_603613941 | 658 | 2 | ||
TI_59383927 | INCYTE_603629605 | RPS7.eAug10 | 793 | 748 | INCYTE_603629605 | 650 | 1 | ||
TI_59385104 | INCYTE_603631175 | RPS7.eAug10 | 724 | 688 | INCYTE_603631175 | 585 | 11 | ||
TI_59385404 | INCYTE_603631772 | RPS7.eAug10 | 789 | 786 | INCYTE_603631772 | Anomalous_clone | 684 | 3 | |
TI_59385619 | INCYTE_603632068 | RPS7.eAug10 | 721 | 682 | INCYTE_603632068 | 579 | 8 | ||
TI_59391977 | INCYTE_603639670 | RPS7.eAug10 | 793 | 751 | INCYTE_603639670 | 664 | 2 | ||
TI_59392044 | INCYTE_603639746 | RPS7.eAug10 | 762 | 722 | INCYTE_603639746 | 632 | 22 | ||
TI_59392332 | INCYTE_603640057 | RPS7.eAug10 | 515 | 433 | INCYTE_603640057 | Anomalous_clone | 336 | 4 | |
TI_59392354 | INCYTE_603640079 | RPS7.eAug10 | 793 | 733 | INCYTE_603640079 | 638 | 4 | ||
TI_59392482 | INCYTE_603640225 | RPS7.eAug10 | 789 | 440 | INCYTE_603640225 | Anomalous_clone | 345 | 0 | |
TI_59392721 | INCYTE_603640492 | RPS7.eAug10 | 792 | 740 | INCYTE_603640492 | Anomalous_clone | 652 | 2 | |
TI_59392805 | INCYTE_603640595 | RPS7.eAug10 | 793 | 741 | INCYTE_603640595 | 645 | 11 | ||
N85270 | J3047 | RPS7.eAug10 | 312 | 148 | J3047 | 148 | 13 | ||
M77233 | M77233 | RPS7.eAug10 | 776 | 600 | M77233 | 600 | 1 | ||
BY994077 | MCN0427 | RPS7.eAug10 | 792 | 573 | MCN0427 | Anomalous_clone | 548 | 6 | |
BY994574 | MCN0924 | RPS7.eAug10 | 784 | 657 | MCN0924 | 633 | 6 | ||
BY995033 | MCN1383 | RPS7.eAug10 | 792 | 683 | MCN1383 | Anomalous_clone | 641 | 6 | |
DA649761 | MESAN2003058 | RPS7.kAug10 | 970 | 553 | MESAN2003058 | 552 | 0 | ||
DB321661 | MESAN2003058 | RPS7.kAug10 | 3001 | 1 | MESAN2003058 | 556 | 1 | ||
DA656445 | MESAN2012119 | RPS7.mAug10 | 575 | 576 | MESAN2012119 | 575 | 3 | ||
DV461736 | n1867 | RPS7.eAug10 | 410 | 1 | n1867 | Inverted | 213 | 1 | |
DV461736 | n1867 | RPS7.eAug10 | 410 | 1 | n1867 | Inverted | 213 | 1 | |
DV460226 | n3101 | RPS7.eAug10 | 410 | 1 | n3101 | Inverted | 169 | 2 | |
DV460226 | n3101 | RPS7.eAug10 | 410 | 1 | n3101 | Inverted | 169 | 2 | |
DV460474 | n3195 | RPS7.eAug10 | 410 | 141 | n3195 | 141 | 0 | ||
DV460474 | n3195 | RPS7.eAug10 | 410 | 141 | n3195 | 141 | 0 | ||
DV461358 | n3243 | RPS7.eAug10 | 410 | 141 | n3243 | 141 | 0 | ||
DV461358 | n3243 | RPS7.eAug10 | 410 | 141 | n3243 | 141 | 0 | ||
DV460848 | n6438 | RPS7.eAug10 | 405 | 214 | n6438 | 214 | 3 | ||
DV460848 | n6438 | RPS7.eAug10 | 405 | 214 | n6438 | 214 | 3 | ||
NM_001011.3 | NM_001011 | RPS7.eAug10 | 792 | 727 | NM_001011 | Anomalous_clone | 727 | 0 | |
AV751200 | NPCCOC02 | RPS7.eAug10 | 373 | 149 | NPCCOC02 | 149 | 13 | ||
DB365653 | NT2RP2003539 | RPS7.eAug10 | 789 | 1 | NT2RP2003539 | 575 | 9 | ||
DB366597 | NT2RP2005338 | RPS7.eAug10 | 792 | 1 | NT2RP2005338 | 548 | 16 | ||
DA758549 | NT2RP8006429 | RPS7.kAug10 | 553 | 556 | NT2RP8006429 | 555 | 2 | ||
DA783801 | OCBBF2019980 | RPS7.iAug10 | 3109 | 468 | OCBBF2019980 | 467 | 3 | ||
CV574227 | oe21h01 | RPS7.eAug10 | 772 | 633 | oe21h01 | 633 | 0 | ||
CV574227 | oe21h01 | RPS7.eAug10 | 772 | 633 | oe21h01 | 633 | 0 | ||
DA828044 | PLACE1000331 | RPS7.eAug10 | 791 | 665 | PLACE1000331 | 664 | 3 | ||
DB372454 | PLACE1000331 | RPS7.eAug10 | 792 | 1 | PLACE1000331 | 295 | 1 | ||
DA882403 | PUAEN2001932 | RPS7.iAug10 | 2887 | 533 | PUAEN2001932 | 532 | 4 | ||
CR977085 | RZPDp9016A0718 | RPS7.fAug10 | 1045 | 705 | RZPDp9016A0718 | 705 | 0 | ||
CT002471 | RZPDp9016F0234 | RPS7.fAug10 | 1000 | 687 | RZPDp9016F0234 | 687 | 1 | ||
BM746174 | S4SNU1-1-G06 | RPS7.eAug10 | 366 | 207 | S4SNU1-1-G06 | 207 | 0 | ||
F35482 | s4v-000156-0/A12 | RPS7.jAug10 | 302 | 254 | s4v-000156-0/A12 | 254 | 4 | ||
BM756952 | S6SNU620-23-G01 | RPS7.eAug10 | 378 | 205 | S6SNU620-23-G01 | 205 | 1 | ||
BM756952 | S6SNU620-23-G01 | RPS7.eAug10 | 378 | 205 | S6SNU620-23-G01 | 205 | 1 | ||
BM828407 | S11SNU1-32-E02 | RPS7.eAug10 | 767 | 671 | S11SNU1-32-E02 | 671 | 0 | ||
BM835860 | S11SNU1-74-D05 | RPS7.bAug10 | 430 | 430 | S11SNU1-74-D05 | 430 | 1 | ||
BM791268 | S21SNU520-18-H08 | RPS7.eAug10 | 791 | 664 | S21SNU520-18-H08 | 664 | 0 | ||
BM798231 | S22SNU16n1-81-G02 | RPS7.dAug10 | 184 | 185 | S22SNU16n1-81-G02 | 185 | 3 | ||
BM798231 | S22SNU16n1-81-G02 | RPS7.dAug10 | 184 | 185 | S22SNU16n1-81-G02 | 185 | 3 | ||
TI_1948145457 | SC_11075_4_B3 | RPS7.eAug10 | 644 | 606 | SC_11075_4_B3 | 474 | 10 | ||
DA908799 | SKNSH2001128 | RPS7.gAug10 | 556 | 558 | SKNSH2001128 | 557 | 1 | ||
DA937142 | SPLEN2009835 | RPS7.lAug10 | 547 | 548 | SPLEN2009835 | 547 | 1 | ||
DB102604 | THYMU2001917 | RPS7.eAug10 | 682 | 555 | THYMU2001917 | 554 | 0 | ||
DB107303 | THYMU2009084 | RPS7.dAug10 | 585 | 569 | THYMU2009084 | 568 | 0 | ||
DB135481 | THYMU3006453 | RPS7.kAug10 | 558 | 557 | THYMU3006453 | 556 | 0 | ||
DB139612 | THYMU3012269 | RPS7.kAug10 | 535 | 535 | THYMU3012269 | 534 | 1 | ||
DB155352 | THYMU3033641 | RPS7.kAug10 | 585 | 584 | THYMU3033641 | 583 | 1 | ||
TI_149271961 | TI_149271961 | RPS7.eAug10 | 789 | 96 | TI_149271961 | Anomalous_clone | 499 | 3 | |
TI_149273298 | TI_149273298 | RPS7.eAug10 | 775 | 703 | TI_149273298 | Inverted | 648 | 9 | |
TI_149273773 | TI_149273773 | RPS7.eAug10 | 793 | 717 | TI_149273773 | Inverted | 665 | 10 | |
TI_149274865 | TI_149274865 | RPS7.cAug10 | 411 | 86 | TI_149274865 | 378 | 0 | ||
TI_149275478 | TI_149275478 | RPS7.eAug10 | 792 | 88 | TI_149275478 | Anomalous_clone | 617 | 0 | |
TI_149286814 | TI_149286814 | RPS7.eAug10 | 792 | 78 | TI_149286814 | Anomalous_clone | 640 | 1 | |
TI_149289678 | TI_149289678 | RPS7.eAug10 | 792 | 734 | TI_149289678 | Inverted | Anomalous_clone | 647 | 5 |
TI_149313094 | TI_149313094 | RPS7.eAug10 | 792 | 88 | TI_149313094 | Anomalous_clone | 652 | 0 | |
TI_154015939 | TI_154015939 | RPS7.eAug10 | 792 | 86 | TI_154015939 | Anomalous_clone | 641 | 0 | |
TI_154019208 | TI_154019208 | RPS7.eAug10 | 792 | 92 | TI_154019208 | Anomalous_clone | 358 | 1 | |
TI_154047908 | TI_154047908 | RPS7.eAug10 | 792 | 97 | TI_154047908 | Anomalous_clone | 693 | 8 | |
TI_154050883 | TI_154050883 | RPS7.eAug10 | 792 | 92 | TI_154050883 | Anomalous_clone | 640 | 5 | |
TI_154124454 | TI_154124454 | RPS7.fAug10 | 1424 | 69 | TI_154124454 | Anomalous_clone | 656 | 6 | |
TI_154133424 | TI_154133424 | RPS7.eAug10 | 792 | 110 | TI_154133424 | Anomalous_clone | 640 | 6 | |
TI_154141267 | TI_154141267 | RPS7.eAug10 | 674 | 577 | TI_154141267 | 489 | 9 | ||
TI_154141347 | TI_154141347 | RPS7.eAug10 | 690 | 585 | TI_154141347 | 501 | 0 | ||
TI_154141615 | TI_154141615 | RPS7.eAug10 | 764 | 657 | TI_154141615 | 578 | 18 | ||
TI_154141668 | TI_154141668 | RPS7.eAug10 | 792 | 692 | TI_154141668 | 612 | 4 | ||
TI_154141816 | TI_154141816 | RPS7.eAug10 | 786 | 733 | TI_154141816 | 653 | 29 | ||
TI_154142499 | TI_154142499 | RPS7.eAug10 | 792 | 692 | TI_154142499 | Anomalous_clone | 601 | 16 | |
TI_154146735 | TI_154146735 | RPS7.eAug10 | 604 | 526 | TI_154146735 | 443 | 6 | ||
TI_154182351 | TI_154182351 | RPS7.eAug10 | 793 | 776 | TI_154182351 | Anomalous_clone | 673 | 27 | |
TI_154183565 | TI_154183565 | RPS7.eAug10 | 791 | 787 | TI_154183565 | Anomalous_clone | 697 | 11 | |
TI_154184946 | TI_154184946 | RPS7.eAug10 | 792 | 648 | TI_154184946 | Anomalous_clone | 540 | 8 | |
TI_154190585 | TI_154190585 | RPS7.eAug10 | 800 | 592 | TI_154190585 | 414 | 14 | ||
TI_154191718 | TI_154191718 | RPS7.eAug10 | 792 | 478 | TI_154191718 | Anomalous_clone | 428 | 1 | |
TI_154192621 | TI_154192621 | RPS7.eAug10 | 790 | 650 | TI_154192621 | 600 | 9 | ||
DB213765 | TRACH3001917 | RPS7.iAug10 | 2408 | 558 | TRACH3001917 | 557 | 1 | ||
DB232618 | TRACH3026588 | RPS7.lAug10 | 553 | 554 | TRACH3026588 | 553 | 1 | ||
BQ028517 | UI-1-EE0-ayz-i-07-0-UI | RPS7.eAug10 | 792 | 19 | UI-1-EE0-ayz-i-07-0-UI | Anomalous_clone | 655 | 0 | |
BQ028517 | UI-1-EE0-ayz-i-07-0-UI | RPS7.eAug10 | 792 | 19 | UI-1-EE0-ayz-i-07-0-UI | Anomalous_clone | 655 | 0 | |
CF541148 | UI-CF-EC1-adz-k-05-0-UI | RPS7.dAug10 | 672 | 19 | UI-CF-EC1-adz-k-05-0-UI | Anomalous_clone | 632 | 0 | |
BM662445 | UI-E-CI1-abg-f-03-0-UI | RPS7.eAug10 | 789 | 16 | UI-E-CI1-abg-f-03-0-UI | Anomalous_clone | 499 | 0 | |
BM662445 | UI-E-CI1-abg-f-03-0-UI | RPS7.eAug10 | 789 | 16 | UI-E-CI1-abg-f-03-0-UI | Anomalous_clone | 499 | 0 | |
BM708102 | UI-E-CI1-aft-h-03-0-UI | RPS7.eAug10 | 582 | 440 | UI-E-CI1-aft-h-03-0-UI | 440 | 0 | ||
BM708102 | UI-E-CI1-aft-h-03-0-UI | RPS7.eAug10 | 582 | 440 | UI-E-CI1-aft-h-03-0-UI | 440 | 0 | ||
BM668726 | UI-E-CK1-afm-h-22-0-UI | RPS7.eAug10 | 792 | 19 | UI-E-CK1-afm-h-22-0-UI | Anomalous_clone | 296 | 0 | |
BM668726 | UI-E-CK1-afm-h-22-0-UI | RPS7.eAug10 | 792 | 19 | UI-E-CK1-afm-h-22-0-UI | Anomalous_clone | 296 | 0 | |
BM693449 | UI-E-CK1-afm-h-22-0-UI | RPS7.eAug10 | 558 | 362 | UI-E-CK1-afm-h-22-0-UI | Anomalous_clone | 362 | 0 | |
BM693449 | UI-E-CK1-afm-h-22-0-UI | RPS7.eAug10 | 558 | 362 | UI-E-CK1-afm-h-22-0-UI | Anomalous_clone | 362 | 0 | |
BM696533 | UI-E-DW0-agk-e-23-0-UI | RPS7.eAug10 | 735 | 563 | UI-E-DW0-agk-e-23-0-UI | 561 | 4 | ||
BM696533 | UI-E-DW0-agk-e-23-0-UI | RPS7.eAug10 | 735 | 563 | UI-E-DW0-agk-e-23-0-UI | 561 | 4 | ||
BM700073 | UI-E-DW1-aha-i-02-0-UI | RPS7.eAug10 | 789 | 524 | UI-E-DW1-aha-i-02-0-UI | Anomalous_clone | 524 | 0 | |
BM700073 | UI-E-DW1-aha-i-02-0-UI | RPS7.eAug10 | 789 | 524 | UI-E-DW1-aha-i-02-0-UI | Anomalous_clone | 524 | 0 | |
BU737874 | UI-E-DW1-aha-i-02-0-UI | RPS7.eAug10 | 789 | 17 | UI-E-DW1-aha-i-02-0-UI | Anomalous_clone | 293 | 0 | |
BU737874 | UI-E-DW1-aha-i-02-0-UI | RPS7.eAug10 | 789 | 17 | UI-E-DW1-aha-i-02-0-UI | Anomalous_clone | 293 | 0 | |
CA437118 | UI-H-DT0-avj-p-12-0-UI | RPS7.eAug10 | 792 | 19 | UI-H-DT0-avj-p-12-0-UI | Anomalous_clone | 641 | 0 | |
CA437118 | UI-H-DT0-avj-p-12-0-UI | RPS7.eAug10 | 792 | 19 | UI-H-DT0-avj-p-12-0-UI | Anomalous_clone | 641 | 0 | |
BQ771964 | UI-H-EZ1-bbk-j-23-0-UI | RPS7.eAug10 | 792 | 19 | UI-H-EZ1-bbk-j-23-0-UI | Anomalous_clone | 638 | 1 | |
BQ771964 | UI-H-EZ1-bbk-j-23-0-UI | RPS7.eAug10 | 792 | 19 | UI-H-EZ1-bbk-j-23-0-UI | Anomalous_clone | 638 | 1 | |
CA430606 | UI-H-FH1-bft-l-14-0-UI | RPS7.eAug10 | 792 | 19 | UI-H-FH1-bft-l-14-0-UI | Anomalous_clone | 655 | 0 | |
CA430606 | UI-H-FH1-bft-l-14-0-UI | RPS7.eAug10 | 792 | 19 | UI-H-FH1-bft-l-14-0-UI | Anomalous_clone | 655 | 0 | |
BU633488 | UI-H-FL1-bgu-j-14-0-UI | RPS7.eAug10 | 789 | 19 | UI-H-FL1-bgu-j-14-0-UI | Anomalous_clone | 638 | 0 | |
BU633488 | UI-H-FL1-bgu-j-14-0-UI | RPS7.eAug10 | 789 | 19 | UI-H-FL1-bgu-j-14-0-UI | Anomalous_clone | 638 | 0 | |
CA306668 | UI-H-FT1-bht-g-06-0-UI | RPS7.eAug10 | 792 | 19 | UI-H-FT1-bht-g-06-0-UI | Anomalous_clone | 646 | 0 | |
CA306668 | UI-H-FT1-bht-g-06-0-UI | RPS7.eAug10 | 792 | 19 | UI-H-FT1-bht-g-06-0-UI | Anomalous_clone | 646 | 0 | |
CA309704 | UI-H-FT1-bic-b-03-0-UI | RPS7.eAug10 | 792 | 19 | UI-H-FT1-bic-b-03-0-UI | Anomalous_clone | 632 | 1 | |
CA309704 | UI-H-FT1-bic-b-03-0-UI | RPS7.eAug10 | 792 | 19 | UI-H-FT1-bic-b-03-0-UI | Anomalous_clone | 632 | 1 | |
DB252727 | UTERU2007082 | RPS7.kAug10 | 582 | 581 | UTERU2007082 | 580 | 0 | ||
DB254053 | UTERU2008872 | RPS7.lAug10 | 494 | 497 | UTERU2008872 | 496 | 2 | ||
X74803 | X74803 | RPS7.eAug10 | 738 | 180 | X74803 | 171 | 6 | ||
AU077323 | Zrv6c661 | RPS7.eAug10 | 221 | 94 | Zrv6c661 | 94 | 0 | ||
BP381026 | Zrv6c661__1 | RPS7.eAug10 | 716 | 588 | Zrv6c661__1 | 588 | 4 |